Podcasts about structural

Today's West Coast Cookbook & Speakeasy Podcast for our especially special Daily Special, Blue Moon Spirits Fridays, is now available on the Spreaker Player!Starting off in the Bistro Cafe, airlines are cutting flights, companies are cutting deliveries and oil companies are cutting refineries, because Trump has run out of diesel.Then, on the rest of the menu, University of Texas-Austin is cutting majors centering on Latino, Black, women and gender studies; Milwaukee police swatted an innocent couple fifty-five times in a single year, only stopping after they filed a $575,000 dollar lawsuit; and, Whiskey Pete and his wife's massive European troop withdrawal plan sparks an immediate backlash.After the break, we move to the Chef's Table where the Hague convicted Kosovo's former President Thaci of war crimes committed during the 1998-99 Serbian war, sentencing him to twenty-five years; and, Malaysia's king has allowed former leader Najib to serve the rest of his graft sentence under house arrest.All that and more, on West Coast Cookbook & Speakeasy with Chef de Cuisine Justice Putnam.Bon Appétit!The Netroots Radio Live PlayerKeep Your Resistance Radio Beaming 24/7/365!“Structural linguistics is a bitterly divided and unhappy profession, and a large number of its practitioners spend many nights drowning their sorrows in Ouisghian Zodahs.” ― Douglas Adams “The Restaurant at the End of the Universe”Become a supporter of this podcast: https://www.spreaker.com/podcast/west-coast-cookbook-speakeasy--2802999/support.

In this episode, I have the pleasure of speaking with Dr. Neil Nathan about the intersection between brain symptoms and complex illness. Dr. Nathan has practiced medicine for over 50 years. He is one of the leading experts in complex chronic illness and mold toxicity — author of the bestselling Toxic: Heal Your Body from Mold Toxicity, Lyme Disease, Multiple Chemical Sensitivity, and Chronic Environmental Illness and The Sensitive Patient's Healing Guide. I am grateful to call Dr. Nathan a mentor and colleague. His pioneering work has been responsible for my healing from chronic illness, as well as that of many patients I've treated. Together, we co-lead a small peer group (within the larger mentoring group he provides with Marie Matheson, ND), supporting practitioners who treat those with complex chronic illness.In this episode we discuss:03:43 – Dr. Nathan's path to understanding complex illness11:20 – Why complex illness is rising and underrecognized19:30 – Why new medical ideas take decades to reach patients23:15 – Mold, Lyme, and long-COVID: the “big three” root causes25:58 – The limbic-vagal-mast cell “trifecta”30:31 – Are some people born more vulnerable?44:39 – The risk in “just do limbic retraining” advice47:35 - Biochemical contributors49:26 – Structural root: jaw and cervical instability53:58 – Differentiating Between Mold, Lyme & Long-COVID58:49 – A message of hope, and where to learn moreFull Transcript belowYou can find Dr. Nathan's books, consultations and mentoring program through his website at neilnathanmd.com. If you'd like to help get this information out into the world, please consider liking, sharing, or commenting.Until next time,CourtneyCourtney Snyder MDDr. Courtney Snyder MD is a holistic and functional child and adult psychiatrist and host of the Holistic Psychiatry Podcast and can be found at courtneysnydermd.comMedical DisclaimerThis podcast is for educational purposes only and is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment. Consult your own physician for any medical issues you may be having.Full TranscriptDr. Nathan's Path to Understanding Complex Illness03:43Courtney: I'm so glad we're doing this, and I feel like it's long overdue. As you know, in the mental health space in psychiatry, there's a lot of recognition of a dysregulated nervous system, threat response in the body, but oftentimes that's attributed to external forces or trauma, and not necessarily internal threats that we see, obviously, in complex chronic illness, which we'll be talking about. There's also not the recognition of the relationship between physical symptoms and brain-related symptoms. So I know you're going to help us connect a lot of these dots. As we sort of just lay the groundwork for what complex chronic illness is — when in your path did you start to recognize the distinction, when was the beginning of your work and appreciation of complex health issues?Neil: Okay, there are two answers to that question. First, when I went to medical school, my hope was to become a healer. And I was very disappointed that when I got there, I realized they weren't going to teach me to be a healer. And back then I used to question my professors at medical school — why do you do it this way, and how is that? And I kept feeling in all of our interactions that we were missing something. And my professors would go, “Okay, Mr. Wise Guy, smart guy, what are we missing?” And I'd go, “I don't know, I just know we're missing something.” Later I would come to recognize that we were missing the emotional and spiritual component to whatever was affecting people in their illnesses. And I have language for it now — I didn't then. The person in medical school who influenced me the most was Elisabeth Kübler-Ross, who I view as my main mentor in medical school. She, unlike anyone else, had a one-and-a-half-hour seminar once a week. Back then there weren't video cameras — you were in a small confined room with a two-way mirror, and you're sitting there watching someone do this. And she would simply interview one of her patients. She was a psychiatrist, but she was the only one in medical school who demonstrated how to really listen to people, how to really communicate with them, and not have this standard review of systems — here's my questions, here's your answers, and that's what I do, and this is what I write up. She was really listening. She was trying to really take in, okay, what happened to you, and what's going on with you? So I would want to give her credit as a role model to change how I learn to listen. Okay, that was step one.I'm going to fast forward to the early 1980s. And I am, at that point, the medical director of a regional pain clinic. And we are starting to see a whole bunch of patients who had this complicated process of fatigue, unrefreshed sleep, irritable bowel syndrome, and pain migrating all over their body. And back then we called it fibrositis. Now we call this fibromyalgia. And so whenever medicine encounters a thing that they don't know what they're looking at, it's psychological until proven otherwise. And people would get therapy, and they would take antidepressants and anti-anxiety agents. Didn't help much. And so it became clear to me that we didn't understand what this was at all. It was not psychological. Something was going on in their bodies — now I recognize it as an inflammatory process. Back then there was no concept of that at all. And then, slowly, in the early nineties, we began to find pieces of the puzzle to understand what was triggering fibromyalgia. I was working back then with Jacob Teitelbaum, who did a lot of work with chronic fatigue and fibromyalgia, and we both independently came up with an understanding that a deficiency of magnesium, DHEA, adrenal issues, thyroid issues, sex hormone deficiencies, GI dysbiosis, and food allergy — if we looked at those and treated those, the majority of people with fibromyalgia got cured. It was different for different patients. It was not like there was one thing that caused it. And as time evolved, we began to realize that there was lots of other biochemical imbalances in the body that would contribute to this kind of a process that represented chronic fatigue and fibromyalgia.We discovered that Lyme disease and coinfections was a huge piece of that. And later still we discovered that mold toxicity was a huge piece of that. And so my understanding of the complexity — and it's not really confined to chronic fatigue and fibromyalgia at this point, we're really talking about almost all chronic illness — with a huge psychological component to that. So we've begun to understand this as essentially some version of inflammation. And if we start to really dig into what are the potential causes of that inflammation, we can make a huge impact for them. So this is a multi-year evolving understanding of how a person's genetics, biochemistry, physiology impacts their whole being in every way. And that inflammation extends to the nervous system, contributing greatly, if not causing directly, a large number of what are now called psychiatric diagnoses.Courtney: Right. So even among those patients that you were seeing — you were seeing, I'm assuming, depression, anxiety, brain fog?Neil: Yeah, the vast majority of our patients with mold toxicity have brain fog and anxiety, depression, OCD behaviors, mood swings, depersonalization, derealization. I mean, all of that is super common in our patients.Complex Illness Is Rising — and Underrecognized11:20Courtney: Do you feel like this is more recognized now — or do you feel like the number of people being hit with these complex health issues is increasing — or both?Neil: Both. I would love to say that the medical profession is increasingly recognizing all of this as important, but that recognition is coming very, very slowly. The majority of folks out there, if they were to list the symptoms that they had, their doctors would basically look at them like, “I have no idea what's causing it, so this must be in your head.” And that is the message they're getting from their physicians at this point. So many patients are being gaslighted, so many patients are being told it's in your head. And the repercussions of that are the family is hearing that same message, and the families become less supportive of those people, because they're saying, “This is not real, so why would I support you? This is still in your head, go get your head fixed.” And they're wrong, and it's really a travesty. But so yes, very slowly, this awareness is growing. There are now more medical meetings that I'm aware of where psychiatrists can learn more about this than there were ten, fifteen years ago, for sure. But not enough — it's still not enough.The other part of that is some of the main triggers for this inflammatory process are increasing. So we're seeing more and more mold toxicity, we're seeing more and more Lyme and coinfections, partly because the environment that we are all exposed to has gotten extremely increasingly toxic. So it's now known, for example, that there are 350,000 new chemicals in our environment than existed 70 years ago. The vast majority of those have never been tested for safety in human beings. So human beings have a tremendous amount of chemical exposure that they never had before. Human beings have a tremendous amount of EMF, electromagnetic exposures that they never had before in the history of the human race. So these exposures are cumulative. Our major organs, like our liver and our kidney, that have to deal with toxicity, are overloaded. And so, yes, we are seeing an epidemic of a whole bunch of these conditions. In children, we are aware that autism has skyrocketed — it went from one in several thousand kids to one in thirty kids in many states now have autism. And forgive me, but the pediatric profession is not taking this seriously. It's like, “Yeah, that's sad, it's unfortunate.” It's like — really, you don't want to look at this? This means one in every three kids born are getting autism — does that not concern you? But, forgive me, the medical profession is very slow to embrace new information, and that is really to the detriment.We're seeing an epidemic of Alzheimer's, Parkinson's, ALS, all of which involve neuroinflammation. We've seen already an epidemic of chronic fatigue and fibromyalgia. And all of these things are interrelated, because — yes, I'm supposed to be an expert on mold toxicity, and I probably am — but mold toxicity doesn't exist in a vacuum. You have mold toxicity as one of multiple environmental toxins we're being exposed to. It is simply one of the most common, the easiest one to diagnose, because we have tests for it. We don't have tests for the hundreds of thousands of chemicals out there. We're just beginning to be able to have some tests that will tell us what's in someone's body that might be making them sick.Courtney: Right, right. And I would imagine that this typical medical model of looking for one cause to autism, one cause to dementia — it's a completely different way of thinking. When you get away from that and you look at complexity of the human body, that way of thinking holds back the research, it holds back any progress.Neil: What I think is helpful for people to look at is: we are all uniquely, biochemically, genetically different. And so the same inflammation in one person could trigger cardiovascular disease, and another person could trigger Alzheimer's, and another person could trigger chronic fatigue. So we need to take a step back and go, okay — and this is not a brand new idea. For the last ten years, there are many papers in the medical journals that are saying chronic illness is almost certainly an inflammatory process. Now, it hasn't really integrated into what people are being taught in medical school or in their residency program. But this is not a brand new idea, and there's tons of medical research documenting that.What behooves us as physicians is to look at every human being and go, “Okay, this is your named chronic condition — what are the triggers for you?” We have to kind of be like a medical detective and dig in and go, okay, what's triggering your inflammation, so I can treat the cause — not put a band-aid on it, which is, forgive me, in the psychiatric field, taking antidepressants and benzodiazepines. That's a band-aid. It's a helpful band-aid, it could be a very important band-aid, help someone to function. But you really need to be looking at, okay, I have this great band-aid, but wouldn't it be nice to actually cure this? And I think that would be, for me, to your audience, Courtney, my take-home message — which is always look for the root cause, because it is possible that we will find that root cause, and you won't have whatever name you've been given, depression, anxiety, OCD, for the rest of your earthly life. Maybe.And I've treated thousands of people successfully here. So this is not — I've had one or two successes here — we're talking thousands of people that have responded to this way of practicing medicine, with fabulous results. People who've been literally bedridden, incapacitated by their illness, are now out there working again and being with their family and living full lives. So that's the take-home message.Courtney: Right. Which makes it so satisfying to treat. And I mean, I can speak to that, having experienced it personally. But at the same time, you do get pushback from other areas of medicine that don't give it necessarily credibility, even though people, on the other side, are thriving and healing, and it's really amazing.New Medical Ideas & Research Take Decades to Reach Patients19:30Neil: You know, the history of all science, including medicine, is: new technology, new drugs are fast-tracked to get into our lives. Ideas, not so much. Typically it takes a generation — twenty, twenty-five years — for a new idea to come into acceptance. And the first reaction of any science, medicine included, is to get into denial, which is, “There isn't enough data to support this concept, and I can't be perceived as practicing bad medicine by embracing a concept that isn't proven yet.” But that means that all of their patients are going to have to wait twenty years — until suffering — until that person goes, “Now there's enough evidence, now I can learn how to do this, and now I'll begin to help you.” I'm not wired that way. I'm wired that if I have a suffering person, and I have something that I can offer them that might help, I'm going to try it. I'm going to do it in the safest way I know how, but I can't leave someone dangling for twenty years and say, “I'm sorry, I have to wait until my profession figures out what to do.” That's not me.I worked at the medical school at the University of Minnesota Duluth for eleven years. And I was not only on the faculty, but I was on the committee that determined what new information was put into the curriculum. For example, AIDS was just coming into vogue at that particular point, and it was obvious that we needed to have courses on AIDS for the medical students, because this was big. What a lot of people wouldn't understand is that each department in a medical school fiercely guards its time allotment. Everyone gets a certain number of hours, and they're not open to adding new things or giving up any of their time slots for anything new. And so what I would watch is, as new information came into the medical school, each department fiercely refused to add any new lectures in their department, or give up any of the time that they had to anybody else to add that information. So we're talking about university politics now — this is not even medicine, this is people guarding their turf. And I don't even think that would occur to any consumers, that that would happen like that — well, certainly, why would that happen in a medical school? Well, it's because human beings are responsible for each department, and they guard their own turf. So it's a kind of an insidious process about how new information isn't embraced by the profession, to go into the medical school curriculum.Mold, Lyme, and Long-COVID: The “Big Three”23:15Courtney: I want to come back to what you were saying about inflammation being at the core of chronic illness and complex chronic illness. And when it comes to complex chronic illness, whether it's SIRS or mast cell activation from mold or Lyme, we talk about multiple systems being affected — the central nervous system, gastrointestinal tract, endocrine, skin, just you name it. If the inflammation then is from a source of oxidative stress or a major insult — would you say that mold toxicity is the most common, or would you put Lyme or now even COVID on a par with that, as far as the deepest roots causing the inflammation? Not that the chemicals, metals, and everything else we're being exposed to aren't at play.Neil: In my experience, those three are the biggies — mold toxicity, Lyme with its co-infections, and long-haul COVID. Those are the three most common. Of those, in my experience, mold is the most common, and the one that has to be treated first if you have some or all of them. So, for example, in people who have long-haul COVID or Lyme, often their body will not respond to that treatment optimally until you first get the mold out. So there's a little hierarchy of what we do, in what order. And then within that hierarchy, there's also an order in which we do things for people to respond optimally. So, for example, mold toxicity will trigger — and Lyme and Bartonella will do the same thing — limbic dysfunction, vagal nerve dysfunction, and mast cell activation in most of our patients. Not all, but in most. And the longer they have it, the more likely those things are going to get triggered. Once somebody does not feel safe — and the systems that we have in our body to monitor that safety and to keep us safe are the limbic system, the vagal system, and mast cell activation — we have to get the body safer, or it will not be able to take what you need to take to treat mold or Lyme or long-haul COVID. People will literally shut down — their limbic system will essentially go, “Mm, I see what you're trying to do there, and I can't let you do it, because I'm not sure that's safe.” And it will literally not allow people to do it.The Limbic-Vagal-Mast Cell “Trifecta”25:58Courtney: So with one of those, or a combination of those, on board, these threat mechanisms would be kicked up — mast cell activation, limbic system dysfunction, autonomic nervous system dysfunction. If they look similar, or a timeline isn't easily helping parse out what might be primary, how able do you feel to make the distinction — versus if mold is present, starting there?Neil: If we look at our patient's symptoms, they will point us clearly to whether there's a limbic or vagal or mast cell piece, to be specific. The limbic system's job involves primarily monitoring and regulating and keeping emotion and sensitivity in check. So any symptoms that involve those two things are limbic almost by definition. So on the sensitivity side, if someone describes an increased sensitivity to light, sound, touch, smell, chemicals, EMFs, food — they're already telling me my limbic system is dysfunctional. In some ways it doesn't matter what the cause is; if someone has this increased sensitivity, regardless of the cause, I know we have to treat their limbic system first.On the vagal side, the symptoms would primarily run into symptoms that involve the autonomic nervous system, which would involve things like temperature dysregulation, palpitations, insomnia, POTS, blood pressure dysregulation, or symptoms that involve the gastrointestinal tract, because the vagus nerve controls almost the entire intestinal tract. So any GI symptoms — gas, bloating, distension, reflux, diarrhea, constipation, abdominal pain — again, that would lead me to go, the vagus is involved here. So by listening to my patient's symptoms, I can immediately know what's dysregulated here, and what my first treatment arm will be — to get the limbic and vagal systems back up and running again at a safer level, because otherwise our patients aren't going anywhere. They can do binders and antifungals and antibiotics for Lyme, and they will get worse. Their body will basically go, “I know I might need that, but why are you doing that? I can't even get to a place of safety to respond. I'm on self-preservation mode here.”And in the mast cell category — again, all of the same symptoms that could be mold or Lyme or long-haul COVID could also be mast cell. Again, it's a multi-systemic process. A tip-off, which I find very helpful, is if someone describes a symptom that comes on immediately after eating, sometimes while eating. Nothing causes that kind of reaction that fast except mast cell activation. Allergy — and most people, if they do have some symptom that comes after eating, they're going to be thinking, “It must be what I ate, what did I just eat?” But it's not food allergy, it's mast cell activation. In that context, many of our patients have already observed that they can eat a particular food one day and have a very strong reaction, and the next day, same food, nothing. And they'll go, “That doesn't make sense — if this was allergy, I ought to react the same way every time.” And so that is classical mast cell activation, which fluctuates. So — for the first part of your question — that's what I'm looking for. When I take a history, when I talk with patients, I'm going to really dig into: are they already manifesting symptoms that clearly tell me what we need to do first, to get them safer, so that now they can respond properly to the treatment that will really get at their root cause.Are Some People Born More Vulnerable?30:31Courtney: I know you take deep timelines when you meet with someone, so you're really accounting for a lot. But one of the things that I think about a lot is: who is most vulnerable? Do some of us come into the world already with a vulnerability similar to Elaine Aron's highly sensitive person model? And then maybe there's trauma, early attachment disruption — and already vulnerabilities — but then the toxic load that we're all experiencing. But then something like mold or Lyme then hits. And then, all the years and all the patients you've seen — I'm curious how many you feel already had sort of a vulnerability. Not that they ever had to really become sick necessarily, but already had a vulnerability.Neil: Honestly, I would say most. Our limbic system evolves from the time we were in our mother's uterus, so that almost no one has had a perfect childhood. And so whatever someone has had to deal with in childhood — it could be recurrent ear infections or throat infections, or it could be a surgical procedure, or it could be parents, both of whom worked and they didn't get enough time, or they could be abusive parents, sexually, physically, verbally abusive — whatever someone has been exposed to, that forces their limbic system to have to deal with it. Because that's the job of the limbic system, is to keep you safe. So your limbic system is basically going, “Okay, I'm just a little thing here, what do I need to do to cope with this?” And so their limbic system slowly, inexorably, becomes more and more hypervigilant to protect them. Let's say someone had an alcoholic parent, and they would come home, and you were never sure what their status would be — and so you'd kind of hold yourself back from that, which is, “I've got to see what this person is showing me, is it safe for me to come up and give them a hug, or do I want to hang out in my room for a bit until whatever this is settles down?” That's the beginning of this limbic hypervigilance process. And then it just goes on through life. So that if you've had difficult relationships, or surgeries, or severe infections, or anything in the physical or emotional or spiritual plane, a betrayal of some type — the limbic system becomes slowly more and more and more hypervigilant, when the straw hits the camel's back. And that straw could be COVID, or Lyme, or mold toxicity, or another infection of some type — that's the straw that breaks the camel's back. At that point the limbic system goes into shutdown, which — we know the vagal system goes into shutdown, literally, that's something the vagal system is trained to do. It's “okay, we are so unsafe that I'm shutting down my systems here.” And so that predisposes to illness. But I want to tie that back to inflammation, which — a lot of people don't understand that the vagus nerve, for example, controls inflammation in the body also. There are branches of the vagus that go to the spleen, to the gut-associated lymphoid tissue, and to the thymus, all of which are major immune organs. And if the vagus is dysfunctional, inflammation can rage out of control. So again, this comes back to understanding this complexity of inflammation, and how we need to both understand it and know where it is we want to look to get at that inflammation. So there is a profound interconnected limbic-vagal-mast cell piece. Each totally connects to the other. There's an interaction between the thousand biochemical mediators that mast cells make and the nervous system itself. So I call this interconnection the trifecta, which is: you can't just treat the limbic system in a vacuum, because if you're not also looking at the vagal and mast cell system, your treatment may be a little bit helpful, or it might not even work at all, until you combine all three — so that you really understand this is a package deal here, in terms of how we work with it.There was one more piece I wanted to add, Courtney, to understanding the inflammation piece: whether or not someone gets mold toxicity or Lyme or COVID depends on how robust their immune system is. So you could have a family living in a moldy environment — one person is really sick, several are a little bit sick, and one is not sick at all. And the one who's not sick at all can easily go, “I'm not sure what's wrong with you all, but I'm fine in this environment, it can't be my environment because I'm fine.” And what they're not understanding is: yes, they are fine, as long as their immune system stays robust. For the others, they were at risk for all of these conditions because their immune system took a hit. And for many people who were living in a moldy environment, during COVID, for example, when we isolated and people were spending twenty-four hours in their home rather than the eight hours out, they were many now being exposed to more mold at home than they were before. I don't think people began to think about that or look at that. So in that environment, whether or not they were affected depends on the hit they took. Now, the things that will hit an immune system to weaken it, and allow whatever's there to manifest, are: COVID was a biggie, any severe infection, a surgical procedure, childbirth, menopause, or any emotional upheaval will weaken that immune system, and then the immune system loses containment, and now we are off to the races. So what I try to convince people who are living in a moldy environment who are well is that they're living with a ticking time bomb. Should they take an immune hit, they will be just as sick as their family member who they're kind of lording it over, which is, “I'm not sick, what's wrong with you?” You'll be right there yourself if you take that hit — to try to help them understand, yeah, you're okay for now, but once your immune system weakens. So I'm trying to tie together the immune system, its ability to regulate inflammation, and this whole process here.Courtney: Right, right. Which I guess is why we call it complex, complex illness.Neil: It is the way human beings are. We're not making up a new word of complex illness — illness was always complex. We're just beginning to understand how complex it always has been.The Limits of Treating Symptoms Alone44:39Courtney: Right, so there's communities out there addressing mast cell activation. There's communities out there addressing POTS and dysautonomia. Communities out there addressing OCD and more obvious limbic-type issues. And then there's the whole mental health field. And the dots aren't getting connected. I mean, I've yet to see someone with OCD — I think it's like eighty to ninety-five percent have mold toxicity as part of the picture.Neil: You know, an example — and I won't name names — is there's an eminent pediatric physician who is very well known for his work in autism, who thought he was ADD his whole life until he recognized that he had mold toxicity and started taking antifungals, and all of a sudden his brain went online and he doesn't have it anymore. So that's just a very clear example of what you're talking about. And what we are talking about is: it's absolutely essential that all people who work in the medical field, all healthcare providers, embrace this complexity, because if you're only working on a piece of it, you will help some people to a certain extent, but you will not help people optimally. I mean, that is the absolute bottom line.The understanding that mast cell activation was huge came in 2016, when Larry Afrin wrote his book, Never Bet Against Occam. It was a huge game changer. When I read his book, it was like, “My goodness, I've been missing this in my patients.” And the whole world embraced this information, so that every medical center in the country now has a mast cell activation clinic. However, they're looking at it as a single thing with a label to it, and they're treating it just that way. They have not recognized that if they don't add limbic and vagal work to it, their treatment is not going to be adequate. And so, yes, they're helping people, but absolutely not optimally. And to make it worse, very few of those clinics have recognized that what's causing mast cell activation, which absolutely needs to be treated, is mold toxicity and Lyme. So people go to these clinics and get a certain amount of help, but they're not being treated comprehensively, which is a pet peeve of mine — which is, come on, if you're going to have a clinic, understand the whole interactions of whatever name it is you're working with. If you're going to be an ENT specialist, understand everything that impacts that area. If you're going to be a cardiologist, understand everything that impacts it. And we just don't see that. We see people kind of in their little box — “No, no, I've learned this, this is what I do, this is how I work” — and it's just unfortunate that they're not looking at the bigger picture.Courtney: Right, I think add to that PANS and PANDAS, because in psychiatry, people feel like they're deep diving because they're getting to PANS and PANDAS. It's like, okay, you've got to go deeper than that, because even those conferences, they talk about the need for treating relapse, and it's just going to keep reoccurring.Neil: I mean, they're using IVIG to help. That's nice, but they're not getting to cause. And we know when PANS and PANDAS first emerged on the scene, it was all about strep, and that was the focus for a long time. But as time emerged, it was very clear that this was a neurological inflammation triggered — here we go, broken record — Lyme, mold, other infectious agents had to be looked for. And if we treated those, you could cure PANS. It wasn't something that needed IVIG for the rest of your earthly life.Courtney: Even among those, would you say very often mold is underlying the mycoplasma, the candida?Neil: I think mold is one of the most missed components to illness that I can think of. If I have a goal in life, it would be to raise the consciousness of our profession as to the importance of mold toxicity, how common it is. We're talking millions and millions of people who are not diagnosed, because their doctors don't know about it, and therefore are not making the diagnosis. I'd love to see the consciousness get to the point that someone would present with these complicated stories and a doctor would say, “Why don't we think about mold toxicity?” That would be the most important thing I would have done in my career.Courtney: Yeah, well, you're certainly raising awareness.Neil: I'm working — it is slow. As we said, I'm working on a twenty-year generational issue here.Courtney: You've mentioned that the underlying source needs to be addressed, but the nervous system and immune systems need to be addressed. So one of the things that comes up with limbic system retraining is: I've had people hear the message that if they just address their limbic and autonomic nervous system, then they wouldn't need to address what I see as an ongoing threat, such as a mold toxin. So I'm hoping you can speak to that, and the importance of these programs, despite that.Neil: Sure. A couple of the better-known limbic retraining programs, the coaches get a little bit zealous about — “limbic retraining is so important, this is all you need to do alone, don't even do anything else, just do limbic retraining.” And I suspect that there are a handful, very few, but a handful of people who've gotten well just doing limbic retraining. If, for example, if you had mold toxicity, if it was relatively new, if you had not colonized, and you moved out of your mold exposure soon, it is possible that the limbic retraining would help reboot it to the point that your immune system rebooted itself and you'd be fine. I believe there are a few people like that. The vast majority of people who have limbic dysfunction — you need to do limbic retraining and vagal retraining. You may also need to do mast cell retraining, and please look for the cause of that. Those are downstream effects, those are not named diagnoses that you treat alone and it fixes it. Please look for at least mold and Lyme, which are the two most common things that are triggering this at this point. And people are getting the wrong message if they think they need to do it in a vacuum. To make it worse, they're being told, “No, no, just do limbic retraining, that's all you need.” And the truth is, no, you need to combine limbic retraining and vagal rebooting and mast cell activation most of the time. And of course you've got to get back to cause.Courtney: Right, I mean I try to liken it to — if they were in an abusive relationship or toxic relationship, they wouldn't just limbic-system their way out of that, if there was an external threat.Biochemical Contributors47:35Neil: No, you've got to fix what's primary here. I want to add to this discussion — we're focusing on inflammation from toxins and infections, but there are also other biochemical issues, some of them downstream, that need to be looked for and addressed in order for people to recover completely. So, for example, Lyme and mold will trigger kryptopyrrole issues, or imbalances in the ratio between zinc and copper, or they'll trigger methylation issues super commonly. And I just wanted to expand this discussion — I know it's complicated enough, but I don't want to oversimplify it either — that there are other biochemical things that we want to be looking for, because they're treatable, and they will help people to heal faster, if we're also addressing methylation, the need for zinc, the need for magnesium or B6 — those are common components of this whole process here. And so I just want to kind of tie that all together for a moment.Courtney: No, I'm glad you did, because those are topics that I talk about here, so it's important to connect those. The other thing I see, because I integrate the Walsh approaches with treating people that have complex health issues, is zinc seems so amazing when it comes to mast cell activation — making sure that's optimized. As well as connective tissue — and that was something else I wanted to ask you about — is structural issues that can be impacting the autonomic nervous system. I just see a lot of people — I inquire about it because I had it myself — but who have upper cervical instability as part of this whole picture.Structural Contributors49:26Neil: Again, all of these things are interrelated, and the physical structure can prevent people from moving forward in several different ways. One is the structure of the jaw and the face — the body puts a priority on teeth occluding properly. And if the teeth don't meet just quite right, and the jaw is a little bit out of structure, people often talk about TMJ — the body basically freaks out, it goes into sympathetic overdrive. And for some patients — it's not common, but I've seen several dozen — where the jaw had to be realigned by a combination of dentists specially trained in this work, working with osteopathic physicians, to realign the jaw. Often in those patients, they couldn't respond to the limbic and vagal treatment until their jaw got realigned.Same thing is true with what you're talking about, as cervical cranial instability, which is basically a weakening of the ligaments at the base of the skull, where it attaches to the first cervical vertebra. Now, these are all again intertwined — for example, it begs the question of what weakens those ligaments. And the answer is: if you have mast cell activation, some of the materials that the mast cell makes weakens the ligaments. So the ligaments get weak, and where the skull attaches to the first cervical vertebra, instead of being pulled apart, like ligaments do, it collapses. And that influences the blood flow to the brain, the nerve flow to the brain. And again, the body recognizes that as a priority, and often you can't get that better — you can't get limbic and vagal response until that gets fixed.So there are a bunch of structural issues that also need to be looked at, when people become overly sensitive and are not responding properly. And there's more in that area. So, for example, there's a chapter by Tasha Turzo, who's an expert on the jaw structure. There's a chapter in there by Andy Maxwell on cervical cranial instability. So that book would give people a really good overview of how complicated things are, and they might, chapter by chapter, get a clue of, “I haven't looked at this piece yet.” I mean, we haven't talked about oxalate or salicylate imbalances, which can add to that. So I just think that is a resource for folks that could really help them understand how they've gotten where they are, and understand the path out.Courtney: Right, right, because not everyone has all of these areas, but certainly could be held back or have a unique something that they could be getting relief from early on in the process. So I think it's both, to the degree that people are able to learn, and your book Toxic, too — it's like an encyclopedia, even if someone doesn't read straight through it, they can go to the mast cell section, or they can go to the Bartonella section.Neil: It was intended to be a readable way to understand this complexity, because it basically will talk about almost everything we've talked about today, and help people to get better understanding. I mean, we've talked about the bigger picture today. We didn't talk about, okay, how do you diagnose Lyme, how do you diagnose mold toxicity, how do you diagnose long-haul COVID, and most important, because this is very complicated, how do you decide which of those is the biggest player that you want to address first?Distinguishing Between Mold, Lyme & Long-COVID53:58Courtney: Right, I have shared resources on diagnosing mold toxicity. Would you comment on your last point — how do you recognize, are you using specific testing that you want to reference, the RealTime?Neil: I do. But I would emphasize, we're taught in medical school that if you really listen to patients, ninety-five percent of the time you will make the diagnosis by history alone. And I don't want to get too focused on testing, because listening to the patient and having them describe in detail what they're going through will really give you the little pieces you need to tease it apart to a certain degree. That's only possible to a certain degree, because there's a huge overlap between the symptoms of Lyme and Bartonella and mold and long-haul COVID and mast cell activation. Huge overlap. So there's little teeny pieces that will tend to lean more in one way than another. And honestly, that's what's required from all of us, literally years of study, to really get a handle on — someone will say something, okay, that's much more of a mold symptom than it is a Lyme symptom, something else. So I do encourage people, if they think they might have mold, to get a urine mycotoxin test. That has revolutionized our ability to make these diagnoses.Courtney: Would you still set RealTime as the preferred? That's what I've communicated to this audience.Neil: I would. Any test can help make the diagnosis, but for follow-up testing, the only one that's been really consistent is RealTime. And you want a follow-up test, so you want to know what your baseline starting is, and then you want to know, okay, am I getting these toxins out of my body? From my perspective, you know that you're done treating it when that RealTime comes back reading not present in every category. We have better tests now for Lyme than we've had in the past. Years ago, our tests were inadequate to say the least. And the CDC recognized years ago that the tests were so inadequate that it was basically a diagnosis made by a physician by examining all of the history and information that you had. That was enough — you didn't need a lab report to make the diagnosis of Lyme disease. A new test that I'm particularly fond of is Bruce Patterson's fourteen-panel cytokine test. This is a test that measures cytokines, which are the molecules of inflammation — cytokines are made by your immune system to deal with, or fight, different inflammational causes. And so what Dr. Patterson has discovered is there's a pattern of cytokines that we see with long-haul COVID, which is different than the pattern we see for Lyme. And I'm working with him now on the pattern for mold. So we can literally look at that test and look at, okay, what is inflaming this person primarily now, because I'm looking at that inflammational pattern, and I can literally read that. Some of my patients will have all of those on a particular test, or only one, but it really helps tease apart what is — I call it public enemy number one for my patient, what do I need to address as root cause right now. So our science is improving as we go here.A Message of Hope — and Where to Learn More58:49Courtney: And that's huge. Before we go — I think all of your books, but I'm thinking specifically about Toxic and The Sensitive Patient — all the information you generously share gives people a lot of hope who've been struggling out there. And I think your mentoring and teaching so many of us helps extend some of that reach. Is there anything you'd want to convey to people out there in the throes of chronic illness who are feeling hopeless and not getting the feedback from their doctors that this is something they can get beyond?Neil: Sure. My take-home message is always: everything we talked about today is treatable. Is there hope in there? You bet there is. But if you are not getting the help you need from whoever you are seeing, find someone who understands these things. For example, I do have on my website a list of physicians that I've trained over the years that I'm comfortable that they really know what they're doing — it's a growing list. There's someone like Courtney, who's been trained for years to do this, she's good at it. Find someone who knows what they're talking about, so that you can get someone who does embrace this complexity, and will look at it in its entirety, and then get you moving in the right direction, doing the right things in the right order. To me, this can be done. I mean, I have personally helped to cure four or five thousand people with mold toxicity, and an equal number of people with Lyme disease. So we can help the vast majority of people that we're seeing. So, regardless of how long you've been sick, if you haven't been properly diagnosed and you haven't gotten the right treatment, you can be helped.Courtney: Right, right, that's great. And for physicians out there who are interested in learning more about complex chronic illness — are there resources you would point to? I'll be sharing your books, because I think those are great references — but also how people can find what you're doing currently.Neil: Sure, my books — particularly with this discussion, Toxic and The Sensitive Patient's Healing Guide would be the two most appropriate. I would add that I have just finished writing a book on this whole subject of inflammation. It's currently being edited, I hope it'll be out by early next year. So if you stay tuned to my website, I'll let people know when that's going to be available. And I think, Courtney, what you're referring to is: I do have a mentorship program for healthcare providers. We now have three hundred and fifty-plus people in the mentorship program, it keeps growing. You were in one of the first groups — we started with eight, and then people kept wanting to get in on it. So we welcome people to join. If you go to my website, which is simply neilnathanmd.com, there's a whole thing which talks about the mentorship and how to sign up for it. So I certainly welcome people who want to learn more.Courtney: And then you offer consultations and professional consultations also?Neil: I do. My consultations — I am, at this point, since I'm semi-retired, not seeing people directly. But I do offer consultations with a patient and their primary treating physician — so we all get on a Zoom together, and we will go over the details of that person's history and their lab work, and I will help outline a treatment program that looks to me like it will get people well. And actually, Courtney, I actually do a lot of that — I'm not really retired, my wife will tell you. I stay pretty busy. I love helping people. I love being able to take this complicated information and tease it apart, so that I can help people to understand what they need to do, in what order, in order to get better.Courtney: And we're all grateful — grateful that you've followed your path, because so many people have benefited personally and professionally. So thank you for bringing your wisdom and expertise, really appreciate it.Neil: You're very welcome, happy to do that.You can find Dr. Nathan's information, consultations, and mentoring program through his website at neilnathanmd.com. If you'd like to help get this information out into the world, please consider liking, sharing, or commenting.Until next time,CourtneyCourtney Snyder MDDr. Courtney Snyder MD is a holistic, functional, and environmental psychiatrist for children and adults. Find her at courtneysnydermd.com and on the Holistic Psychiatry Podcast on all major platforms.Medical DisclaimerThis podcast is for educational purposes only and is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment. Consult your own physician for any medical issues you may be having. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit courtneysnydermd.substack.com

Download your FREE Start, Grow, Scale Roadmap in under 30 seconds: ROADMAP What actually determines whether a business scales or stalls? Emma Sinclair MBE on becoming the youngest person ever to float a company on the London Stock Exchange, why 98.2% of venture capital never reaches women, and how to raise money when the institutions won't back you! Emma Sinclair MBE is a serial entrepreneur and technology founder who took a company public at 29, making her the youngest person ever to do so on the London Stock Exchange. She is the co-founder of a global B2B software company serving some of the world's largest employers, has raised around £25m to date, and has just launched Be My Angel, a campaign to turn ordinary savers into angel investors. She explains: Why the structure you raise money through shapes everything your business can become Why only 1.8% of venture capital goes to women, and why the fix has to come from the bottom up Why crowdfunding isn't just for consumer brands, and how any small business can use it   Chapters 00:00:00 Intro 00:01:13 Taking A Company Public At 29 00:02:18 The Game That Taught Her Money 00:03:40 Trading Student Loans At University 00:06:00 Why Learning Business Is Easier Than Ever 00:07:27 Working From 16 And Where The Work Ethic Came From 00:08:16 Why Her Family Believed In Owning Something 00:10:17 What A Cash Shell Actually Is 00:11:39 When 20% Of The Funding Disappeared Overnight 00:12:19 The Jobs That Built Her Resilience 00:13:29 Writing 12 Letters To 12 Banks 00:15:41 Why Rejection Makes Better Business Owners 00:17:12 Does Work Ethic Decide Success? 00:18:09 The Cost Of Working All The Time 00:19:32 The Reality Of Female Entrepreneurship 00:20:47 Why Only 1.8% Of Funding Reaches Women 00:22:37 Launching Be My Angel 00:24:45 Why She's Crowdfunding Part Of Her Raise 00:25:48 Crowdfunding Explained Simply 00:26:41 Why Women Invest Differently To Men 00:28:53 How Small Businesses Can Use The Crowd 00:31:21 Why Every Founder Needs A Tribe 00:33:27 The Highs And Lows Nobody Sees 00:34:43 Outro   Even More Value:   Download your FREE Start, Grow, Scale Roadmap in under 30 seconds: ROADMAP   Learn how to build a 7 Figure SCALE plan that runs WITHOUT you: SCALE UP   Get Adam's tell-all book about building Million Pound Success: ADAM'S BOOK     Follow Adam Stott's Socials:  LinkedIn | Instagram | YouTube | Coaching

How do some entrepreneurs take on more, make more, and keep growing, while still making it look like a cake walk? There's a version of entrepreneurship that treats stress, complexity, and constant mental effort as proof that you're thinking 'big enough'. But what if the ability to handle more without being consumed by it has less to do with how much you can handle, and more to do with something else entirely? In this episode, you'll discover: The subtle habit that quietly eats up enormous amounts of your brainpower, and what to do instead. What some of the highest-earning entrepreneurs do differently when it comes to the way they use their energy How to make more money without adding more hours, more complexity, or more pressure to your business. Listen now to discover what separates the entrepreneurs who seem unfazed by the demands of growth from the ones who feel like their business is consuming them, and what that difference could mean for you.   Work With Jenna: Decisions on Demand — A practical mini-course designed to help you make cleaner, higher-quality choices,  the kind that unlock momentum, authority, and follow-through. The framework mirrors decision-making principles used in high-stakes environments, adapted for real life and business. The Clarity Accelerator Mastermind — If you want to be surrounded by other visionary entrepreneurs while rapidly aligning your business to the conditions and strategies that let you thrive and excel naturally, this intimate mastermind will stretch you into your next level. Schedule your call today here or visit this page to find out more. Private Coaching — If you're craving the highest level of support, strategy, and partnership to create all the freedom, impact, and success you're designed for, this is the space for it. Schedule you call today here.   Find Jenna on Instagram:  https://www.instagram.com/theuncommonway/  The Uncommon Way is a leadership and business podcast for ambitious women entrepreneurs, founders, and leaders who are scaling companies and expanding their influence. Hosted by business and leadership coach Jenna Harrison, the show explores how power, authority, and leadership capacity shape business growth. Episodes focus on founder leadership evolution, decision-making, team development and stability, and the systemic and strategic shifts that allow companies to scale without overwhelming the person leading them. This podcast is especially relevant for women navigating: Business growth and scaling challenges Increasing leadership responsibility Team expansion and higher-stakes decisions Founder authority and executive presence Identity and leadership evolution during scaling   The Uncommon Way approaches growth differently. Not through hustle, constant self-optimization, or endless inner work, but by upgrading leadership structures, strengthening decisions, and expanding the capacity required to run the company you're building. Topics include: Founder leadership capacity expansion Decision-making at higher levels of responsibility Authority and power dynamics inside scaling businesses Structural business leadership Founder psychology and identity shifts during growth Sustainable scaling and operational clarity Whether you're an experienced founder, a rising leader, or building something that's starting to matter at a bigger level, this podcast helps you access more power and lead accordingly.

SUMMARY In this episode of Whistlekick Martial Arts Radio, host Andrew Adams speaks with Rick Barrett, a seasoned martial artist with a rich background in Tai Chi and other internal martial arts. They discuss Rick's journey into martial arts, the health benefits he experienced through Tai Chi, and the concept of hemispheric synchronization. Rick shares insights on his experiences in push hands competitions and the importance of integrating body, mind, and spirit in martial arts practice. The conversation highlights the transformative power of martial arts and the continuous journey of learning and growth. In this conversation, Rick Barrett shares his journey in martial arts, the inspiration behind his writing, and the challenges he faced in the writing process. He discusses his latest book, 'Tai Chi: A Path to Becoming Superconscious,' exploring the concept of superconsciousness and how it can be accessed through Tai Chi. Rick emphasizes the importance of self-empowerment and the ability to create one's life actively. He also hints at future projects focused on participatory consciousness.   TAKEAWAYS Rick Barrett started his martial arts journey at 29 due to health issues. Tai Chi helped Rick overcome chronic pain and improve his movement. Hemispheric synchronization is key to balancing the body and mind. Rick emphasizes the importance of conscious awareness in martial arts. He has explored various Chinese internal martial arts beyond Tai Chi. Push hands competitions taught Rick to rely on mind and energy over muscle. The journey of martial arts is about continuous learning and exploration. Rick believes in creating the biggest effect with the least effort. Martial arts can lead to a state of superconsciousness and flow. Writing a book can be daunting, but it's rewarding. The blank page can be intimidating for writers. Rick's writing process evolved over the years. Superconsciousness is a state accessible to everyone. Tai Chi can help individuals access their highest abilities. The importance of raising one's spirit in martial arts. Structural tension is crucial in the writing process. Rick's latest book aims to demystify Tai Chi for a Western audience. Future projects will focus on engaging life with one's whole being. To connect with Rick Barrett: rick@rickbarrett.net   Join our EXCLUSIVE newsletter to get notified of each episode as it comes out! Subscribe — whistlekick Martial Arts Radio

Barracuda's recent unification of its reseller, MSP, and services programs into a single partner success structure highlights a continuing trend toward channel consolidation and streamlined partner management among technology vendors. This realignment is designed to provide partners with a unified interface and consistent experience, moving away from segmented, product-specific engagement and instead centralizing processes, portals, and incentives under one program.The most consequential operational development is the consolidation of partner access points, reducing from seven disparate logins to a single portal. According to Barracuda, this centralization supports not only transactional activity but also encompasses partner enablement, updated certifications, automation of onboarding, and incentives tied to the entire customer lifecycle. The company reports that partner engagement through the new portal has exceeded prior benchmarks by over 20% compared to the previous period, with error rates reported below 10%.Supporting developments include Barracuda's adjustment of program features such as launching “Barracuda ONE” and Mastery certifications, adding compliance and AI-focused badges, and introducing a buy-now feature tailored for lower-volume purchases. The company also referenced plans to further modernize renewals, contracts, and support structures to address common channel complaints in billing, contract flexibility, and support availability.For MSPs and IT providers, these changes shift operational dynamics by consolidating vendor dependence and reducing administrative friction, but may also introduce risks related to program uniformity and centralized governance. Reliance on a single vendor-managed platform can concentrate risk if features or support become limiting for certain business models. MSPs should assess the tradeoffs of standardized engagement versus flexibility—especially for scenarios like minimum seat requirements and variable contract terms—and scrutinize the alignment between partner incentives and evolving compliance and technology demands.Supported by: ScalePadHaloPSA

Some Americans are frustrated that affordability has not improved quicker. The US has not built a major oil refinery since 1977. Oil prices have remained high primarily due to limited refining capacity. The Trump administration recently announced the first major oil refinery since 1977. Allowing too many people into our country has created increased prices for food, housing, medical expenses, and nearly every item we purchase. If the immigration crackdown continues, an estimated 15 million foreign-born people will leave the US by the end of president Trump's term. The affordability issues have been created over decades. Fixing these problems takes time. Structural changes this significant typically are a result of bloody revolutions. So far, we have gotten off easy. It is naive to think that enemies of America, the Legacy Media, Globalists, the Uni-Party, Bureaucrats, and Democrats would give up easily. Ferenc shares an extreme client example that had suffered extremely poor performance due to poor indexes, high fees, and low participation rates.  Ferenc explains in detail how he was able to find a product that will increase their potential increased returns 10X based on the past decade historical returns.

In this episode, Dr. Miranda Melcher speaks with Skyler Thompson, Deputy Director, and Jennifer Connet, Legal Advisor, at Human Rights Activists in Iran (HRA). They discuss HRA's origins, its work documenting human rights violations in Iran, and its submission to the German Federal Prosecutor requesting a structural investigation into crimes committed in Iran. Skyler and Jennifer share their journeys into human rights work and introduce HRA, founded inside Iran in 2006 by student activist Keyvan Rafie. They explain how its network of on-the-ground documenters remains central to its work today.The conversation explores the structural investigation requested in Germany, including how it can support evidence collection, identify patterns of violations, and map chains of command for potential future prosecutions. Jennifer discusses the repression of nationwide protests in December 2025 and January 2026, including arrests, forced confessions, and executions. She explains why Germany's universal jurisdiction framework and experience with structural investigations make it an important jurisdiction for accountability.The episode also examines the limitations of pursuing justice in Iran and through the International Criminal Court, the importance of realistic expectations for victims and survivors, and the role of documentation in preserving a historical record. Finally, the guests discuss next steps, including continued evidence collection and cooperation between European jurisdictions.

Today's West Coast Cookbook & Speakeasy Podcast for our especially special Daily Special, Blue Moon Spirits Fridays, is now available on the Spreaker Player!Starting off in the Bistro Cafe, Trump angrily lunged at another Black woman reporter for asking a basic question.Then, on the rest of the menu, the Trump administration accused the UC Berkeley Law School of discriminating against white and Asian students by illegally admitting Black and Hispanic applicants; an innocent county 4-H extension agent picking up piglets for a children's 4-H show, was violently held at gunpoint by cops after a Flock camera confused his forty foot aluminum livestock trailer with a white compact sedan; and, Oregon lawmakers agreed to spend an additional $1.25 million to increase the number of ballot drop boxes across the state in response to Trump's war on voting.After the break, we move to the Chef's Table where Switzerland has published a 200-page dossier on Nazi war criminal Josef “Angel of Death” Mengele; and, Emma Bonino, a leader of campaigns that legalized abortion and divorce in the 1970s in heavily Roman Catholic Italy, against the objections of the Vatican, has died at age 78.All that and more, on West Coast Cookbook & Speakeasy with Chef de Cuisine Justice Putnam.Bon Appétit!The Netroots Radio Live PlayerKeep Your Resistance Radio Beaming 24/7/365!“Structural linguistics is a bitterly divided and unhappy profession, and a large number of its practitioners spend many nights drowning their sorrows in Ouisghian Zodahs.” ― Douglas Adams “The Restaurant at the End of the Universe”Become a supporter of this podcast: https://www.spreaker.com/podcast/west-coast-cookbook-speakeasy--2802999/support.

Tonight at 8:30pm CST, on the Flyover Conservatives show we are tackling the most important things going on RIGHT NOW from a Conservative Christian perspective! What really happened to the three World Trade Center towers on September 11, 2001?Architect Richard Gage, AIA, joins David Whited to challenge the official 9/11 narrative and examine the structural evidence surrounding the collapse of the Twin Towers and World Trade Center Building 7—a skyscraper that was never struck by an airplane. Gage breaks down the buildings' rapid collapses, eyewitness reports of explosions, evidence of extreme temperatures, and materials reportedly discovered in the World Trade Center dust.Why did Building 7 fall nearly symmetrically? Could ordinary office fires account for what happened? And why does Gage believe the evidence warrants a new investigation?This conversation presents Richard Gage's analysis and conclusions so you can examine the evidence and decide for yourself.Learn more about Richard's work at RichardGage911.org.Subscribe to Flyover Conservatives, turn on notifications, and share this interview with someone who is willing to ask difficult questions.Follow and Subscribe on YouTube: https://www.youtube.com/@TheFlyoverConservativesShow To Schedule A Time To Talk To Dr. Dr. Kirk Elliott Go To ▶ https://flyovergold.comOr Call 720-605-3900 ► Receive your FREE 52 Date Night Ideas Playbook to make date night more exciting, go to www.prosperousmarriage.comRichard GageWEBSITE: www.RichardGage911.org Richard Gage, AIA, is a San Francisco Bay Area architect who has spent decades working in the architecture and construction industries. He is the founder and former CEO of Architects & Engineers for 9/11 Truth, an organization that has called for a new investigation into the destruction of the three World Trade Center skyscrapers. For nearly two decades, Gage has studied and presented his analysis of the structural and forensic evidence surrounding their collapses. He has appeared in documentaries, lectures, conferences, and media interviews around the world to challenge the official explanation of the events of September 11, 2001. Today, he continues that work through RichardGage911.org and his documentary project, 9/11: Crime Scene to Courtroom.-------------------------------------------

Everyone wants a house with good bones, but as a home ages, the bones age too. Home improvement expert Bill McAnally joins this episode to share the signs that the structure of your home could use some work and what can be done to mend its bones. Then, he answers listener questions.

Why do transgender communities continue to experience profound health inequities? In Part 2, Tonia Poteat examines the structural and social determinants influencing transgender health, the persistent disparities in HIV prevention and care, and the importance of addressing housing, employment, stigma, and gender affirmation alongside traditional healthcare interventions.  Timestamps:  01:01 – Political Determinants of Health  04:00 – Gender and Racial Minorities – HIV  06:04 – Why Intersectionality is Important in HIV Care  08:52 – Responding to Non-Healthcare Challenges

Most tradies never get off the tools. They work harder, take on more, and stay stuck being the business instead of owning one. Matt Warner broke out of that, and the shift that made it possible had almost nothing to do with the trade itself. Matt started as a carpenter and built Built Structural into a real business, and in this episode he's honest with Michael about how hard that transition actually was. He gets into the identity shift most tradies never make, why letting go of being the best person on the tools is so uncomfortable, and what has to change in your head before anything changes in the business. They dig into the messy early phase where there are no systems and the owner does everything, and the predictable walls that show up as you try to grow. There's a sharp point in here about the specific gaps you have to close to reach the next level, and why most people don't even realise which one is holding them back. Matt and Michael also get into why business really comes down to human behaviour rather than spreadsheets, what genuine clarity does for a team, and a blunt take on hiring that most owners learn the hard way. He closes on how he keeps momentum without burning out, and the mindset that carried him through the stretch where most people quit. If you're a tradie or small business owner stuck doing everything yourself, this conversation shows what it actually takes to break out. In this episode: The identity shift most tradies never make Why getting off the tools is harder than it sounds The messy early phase every business has to survive The specific gaps you have to close to reach the next level Why business is really about human behaviour, not spreadsheets What clarity actually does for a team A blunt truth about hiring most owners learn too late How to keep momentum without burning out Official channel and episode of the Winning Standards Podcast hosted by Michael Mojo. All Rights Reserved. When you're ready to fast track your results, here's 2 ways I can help: This month's intake for The Odyssey is now open. If you've hit a ceiling in your business and know the constraint is you, not your business, this is the breakthrough. Limited intake [Learn more] Stuck, need clarity, or just want to upgrade how you think, lead and perform? Thrive Time is my premier self leadership event. [Secure your seat] Follow Me on Social Media:

Hosts: Ed Jones (Owner – Nutrition World) & Clint Powell A variety of topics all related to living a healthy life Presented by: Nutrition World www.nutritionw.com Broadcasting from the Nooga Dentistry Studio www.noogadentistry.com Production of: Whitfield Media Group www.vitalhealthradio.com Title: Rethinking Bone Health: Osteoporosis, Exercise and Essential Nutrients [0:04:00] Clint's New Book & Ed's eBooks/Publishing Plans Clint introduces his new book: Title: The Room with No Doors: How We Trap Ourselves Defending Our Excuses. Format: Paperback + Kindle, includes some work sections at the back. Focuses on seven common excuses we use to avoid trying solutions, trapping ourselves. Available on Amazon; early sales have pushed it into top rankings in certain Kindle and paperback categories. Another book is already written and queued for release around late October / early November. Ed discusses his own Holistic Navigator eBooks: Topics: staying healthy, getting healthy, sleep, oral hygiene, oxalates, AI for fat loss, the “Core Four” foundational supplements, etc. Currently on theholisticnavigator.com; Ed plans to follow Clint's lead and bring them to Amazon/Kindle. [0:06:37[ Labor Day, Nutrition World Shopify Rollout Ed shares that this Labor Day marks a huge milestone for Nutrition World: Full migration to a Shopify-based system for online business. Compared to the massive move years ago from Brainerd Village to Lee Highway, this is framed as the second biggest event in decades. Acknowledges it's been extremely expensive and complex, but promises major improvements in convenience and efficiency for customers. Announcement: Lisa Bloom (lactation expert from Knoxville) has joined Nutrition World: Deep experience helping mothers through lactation challenges. Notes that without support, ~50% of mothers quit breastfeeding due to difficulty. Lisa will offer consultations at Be Well Labs (near Nutrition World), bookable via NutritionW.com / BeginWithLabs.com. [0:09:50] “Teacher of the Week” & Chronic Pain as a Brain Response Ed introduces a recurring concept: “Teacher of the Week” – highlighting sources of health wisdom. This week's teacher: “Pain Free You” (YouTube channel). Ed has personally counseled with the creator. Core idea: a large portion of chronic pain is generated by the brain as a protective distraction from emotional pain or unresolved inner issues. Featured video: “You Are Not Sick, You Are Scared.” Distinguishes between: Structural pain (like Clint's hip, back, knee issues – “flat tires”) where anatomy is clearly damaged. Chronic, shifting, unexplained pain where the nervous system and fear may be the primary drivers. [0:13:33] Upcoming Events September 16 – Talk at Nutrition World by Katie Poole on optimizing fertility. October 24 – Large-scale Health Fair [0:17:44] Segment with Dr. Curt Dearing: Osteoporosis, Osteopenia & Bone Health Clint re‑introduces the show and brings in Dr. Curt Dearing, clinical pharmacist (~35 years' experience). Curt previews the segment (osteoporosis/osteopenia) and contrasts: Conventional approach: heavy on calcium supplements and prescription drugs (e.g., bisphosphonates like Fosamax). Holistic approach: broader lifestyle interventions – targeted nutrients (vitamin D, vitamin K2, vitamin C, boron, strontium), exercise, and fall prevention. Key critiques of conventional diagnosis: The T‑score system compares bone density to that of a young adult, effectively turning normal age-related bone loss into a “disease.” Similar over‑medicalization compared to blood pressure and cholesterol, which also naturally shift with age. Concerns about bisphosphonates (e.g., Fosamax): Originated from chemicals used to soften irrigation water. Improve bone density numbers on scans but can create denser yet more brittle bones. Side effects: Esophageal ulcerations if not taken properly (must sit upright with full glass of water). Rare but devastating jawbone degeneration (osteonecrosis of the jaw). Long‑term use may increase hip fractures; minimal benefit in men and women > 80. Real fracture risk driver: falls, not just bone density. Most fractures in the elderly occur in people without osteoporosis. Priorities: Muscle mass and strength. Cognitive function to reduce fall risk. Lifestyle foundation for bone health: Exercise is primary: Weight‑bearing and high‑intensity training. Weighted vest especially beneficial for lighter women (they lack constant load on bones). General recommendation: 30–60 minutes, 3–4 times per week, with heart rate around 120 minus age for cardio work (not necessarily with the vest). Diet and acid load: Excess acid‑forming foods (grains, dairy, meat, coffee, sugar) can create acidosis, prompting the body to pull minerals (like calcium) from bone to buffer pH. Malabsorption issues (celiac, GI problems, proton pump inhibitors like Nexium) reduce absorption of calcium, magnesium, etc. Supplement strategy: Calcium: important but typical 1,200 mg/day is likely too high; better range 400–1,000 mg, depending on diet. Excess isolated calcium can increase fracture risk. Vitamin D + Vitamin K2 (MK‑7 form): K2 directs calcium out of arteries and into bones. D and K work synergistically; many combo formulas under‑dose D and K, so often need separate higher‑dose D/K. Optimal vitamin D blood levels: generally 60–70 ng/mL; anything under 40 is likely deficient. Toxicity is rare; usually only with abuse of high‑dose (50,000 IU daily instead of weekly). Other helpful nutrients: Vitamin C, boron, strontium. Strontium should be taken separate from calcium/bone formulas. Vitamin K and blood thinners: Vitamin K is crucial not only for clotting but also for bone and cardiovascular health. Only warfarin (Coumadin) users must tightly regulate vitamin K. Newer anticoagulants (Eliquis, Xarelto) do not require vitamin K restriction. [0:39:03] Segment 3: Labs, Spike Protein, Long COVID & Upcoming “Chicken” Episode Ed shares he is getting blood work at Be Well Labs (BeginWithLabs.com): Specifically testing spike protein levels due to curiosity about long COVID. References a previous guest MD who had repeated COVID infections and very high spike protein levels (~870 vs. normal 30% body fat, exercising less than 3x/week. Caffeine doses tested: 3 mg/kg (roughly 200–210 mg for Ed's weight). 5 mg/kg (~300 mg). 9 mg/kg (~500 mg). Findings: 3–5 mg/kg significantly increased fat oxidation vs. placebo. 9 mg/kg gave no added benefit and led to side effects (nervousness, higher blood pressure). Real‑world translation: About 200–300 mg caffeine pre‑exercise appears ideal for fat‑burning benefits. Examples: Starbucks grande cold brew: ~205 mg. Starbucks grande hot coffee: ~310 mg. Ed plans to use caffeine for life, especially pre‑gym, in this moderate dose range. [0:48:08] Xylitol & Cardiovascular Risk Discussion of new research linking xylitol intake to major adverse cardiovascular events (MACE): Study of ~17,000 people, average age ~61, over 6–30 years. Higher intakes of xylitol were associated with increased risk of cardiac events. Mechanism: around 30 g of xylitol can increase platelet aggregation, thickening the blood and potentially increasing clot risk. Practical implications: Chewing gum with xylitol is likely low risk due to small doses. Biggest concern: 16‑oz canned drinks heavily sweetened with xylitol. Nutrition World will scan store beverages and aim to transition away from xylitol‑sweetened drinks toward stevia‑based options. Brief note: some emerging chatter on stevia and possible neurological effects, but Ed notes that appears tied to genetic vulnerabilities, whereas xylitol issues may be more generalized. [0:50:38] Post‑Stomach Bug Recovery: What to Eat Guidance for recovering from stomach bugs (vomiting/diarrhea): Immediate phase: simple, gentle foods like broth. Special protocol (especially for kids): green bananas + rice. Research suggests green bananas plus rice work significantly better than rice alone for recovery. Crucial step: reintroduce protein as soon as symptoms improve. Protein speeds recovery and supports healing. Early on, protein may be easier to drink (e.g., smoothies, shakes) than to eat as solids. [0:56:48] Fauci Advisor Indictment, EMFs/5G/6G & Final Thoughts Ed mentions news that David Morens, MD (former senior advisor to Anthony Fauci at NIAID) pleaded guilty to conspiracy to defraud the U.S. and could face up to 5 years. Framed as part of a broader process of information “coming out” about the COVID era. EMFs, 5G, and coming 6G: Ed reiterates concerns about EMF/5G exposure and its effects on neurochemistry. Notes that 6G is expected around 2030, raising new concerns. Mentions his use of Blue Shield EMF mitigation devices in the bedroom and for family. Clarifies these do not “block” EMFs (only physical shielding like silver fabric can) but are intended to help the body adapt to EMF stress. Amish & vaccine mandates (brief mention): Amish communities in New York reportedly threatened mass exodus over pressure around vaccines, raising questions about medical mandates and rights. Ed closes with a quality‑of‑life perspective: His goal is not necessarily to live more days, but to live higher‑quality days. Recaps that he's lived “80 mph most of the time” and wants to maintain quality through proactive health choices. The post Radio Show / Podcast – September 6, 2026 first appeared on Vital Health Radio.

#1040 | United led twice away at Everton through Mbeumo and Sesko only to do a very good job of chucking it away late on Merseyside. Ed and Dan dig into the tension between United's new possession-based approach and a back four that isn't built for a higher line. And there are questions about Cunha's role as a false nine again. Then there's a look ahead to the Champions League opener against Sabah in midweek. The episode closes with author Dan Williamson, talking about his new book on United's 1991 Cup Winners' Cup win, If I Hadn't Seen Such Riches. 0:00 Introduction 2:31 Everton 2-2 United: the verdict 5:06 Structural problems and United's new style 8:17 Team selection: Cunha, Bruno 18:56 Goals and defensive errors 23:08 Substitutions and game management 25:02 Bigger picture 28:25 Sabah preview, Champions League 36:02 1991 Cup Winners' Cup memories 39:45 Interview: Dan Williamson If you are interested in supporting the show and accessing a weekly exclusive bonus episode, check out our Patreon page or subscribe on Apple Podcasts. Supporter funded episodes are ad-free. NQAT is available on all podcast apps and in video on YouTube. Hit that subscribe button, leave a rating and write a review on Apple or Spotify. Learn more about your ad choices. Visit podcastchoices.com/adchoices

What if chronic pain isn't simply something to silence—but a message your body is trying to send?In this episode of the Headache Doctor Podcast, Dr. Taves sits down with Leigh Brandon, author of Beyond the Pain, functional medicine provider, manual therapist, and C.H.E.K practitioner, to explore why some people remain stuck in chronic pain despite medications, injections, exercises, or even surgery.Leigh breaks chronic pain down into four potential root-cause categories:Structural and biomechanical problemsMetabolic factors like nutrition, digestion, hormones, and inflammationNervous system dysregulation and sensitizationEmotional factors and traumaThey also discuss why pain can be protective rather than simply harmful, how the nervous system can remain hypersensitive after an injury has healed, and practical ways to start identifying patterns behind your own symptoms.If you've been in pain for years and feel like you've already tried everything, this conversation offers a different framework for understanding what your body may be telling you.

A Republican strategist just put a clock on the Secretary of Defense.This week Army Secretary Dan Driscoll — JD Vance's closest ally in the administration, the man Trump sent to Kyiv to negotiate an end to the Ukraine war — resigned after months of losing fights with Pete Hegseth over Hegseth firing Army generals. Republican consultant Matt Wylie's read: "I don't even think he makes it out of the next two months."Then it gets stranger. Trump calls data centers the "Golden Goose" while every Republican on a ballot runs the other way. The Pentagon takes a 35% stake in Venezuelan oil through an office whose own spokesman says it has no legal authority to take equity stakes — which leads Wylie to call Trump "America's first socialist president." A Postal Service whistleblower says the new federal ballot system can throw out an entire batch. And an AI company shows Congress a $500-a-month surveillance tool that builds an instant dossier on any American.Plus: The Battlefield hits its first-ever dead-even verdict, dark money in Maine reaches $80 per voter, and a MAGA influencer who demanded mass deportations gets deported.Matt Robison and Matt Wylie. One Democrat, one Republican. It's Political Rehab, where PTI meets The Daily Show.CHAPTERS00:00 Cold open00:47 This week on Political Rehab01:00 Driscoll resigns — how long does Hegseth last?03:45 Trump's "Golden Goose" vs. his own party07:20 Does crime pay? The Venezuela oil grab10:45 Election chaos: USPS, DHS, and ICE at the polls13:10 The bipartisan revolt over AI surveillance17:05 THE BATTLEFIELD21:20 Structural indicators22:30 Dark money: $80 per voter in Maine25:15 Who won the week — a first-ever tie26:20 Dose of Hope: take away their phones28:55 Dose of Hope: the deportation of Milo YiannopoulosSubscribe to Worth Knowing for the full written analysis, Midterm HQ, and the weekly livestream: [SUBSTACK LINK]New episode every week. Hit subscribe so you don't miss the next one.#PoliticalRehab #Hegseth #Midterms2026Political Rehab with Matt Robison and Matt Wylie — a bipartisan politics show. Pete Hegseth, Dan Driscoll, JD Vance, Pentagon turnover, data centers and electricity prices, Venezuela oil deal, Office of Strategic Capital, USPS mail ballot rule, Flock cameras, AI surveillance, 2026 midterms, Cook Political Report, dark money.

In this episode, you'll discover: • Why you can know something is right for you and still feel, deep down, like you're not 100% sold. • The secret information revealed every time your curiosity gets piqued by an alternative you hadn't considered, and how to use it to create remarkable new results. • What makes some beliefs "sticky" while others can be knocked sideways by one persuasive conversation. Listen now to discover what your curiosity may be telling you about what you really believe, and how that insight can change what you create next.   Episode Mentioned: 195. What's Catching My Attention: I Let ChatGPT Redesign My Skincare Routine... and It Changed More Than My Skin   Work With Jenna: Decisions on Demand — A practical mini-course designed to help you make cleaner, higher-quality choices,  the kind that unlock momentum, authority, and follow-through. The framework mirrors decision-making principles used in high-stakes environments, adapted for real life and business. The Clarity Accelerator Mastermind — If you want to be surrounded by other visionary entrepreneurs while rapidly aligning your business to the conditions and strategies that let you thrive and excel naturally, this intimate mastermind will stretch you into your next level. Schedule your call today here or visit this page to find out more. Private Coaching — If you're craving the highest level of support, strategy, and partnership to create all the freedom, impact, and success you're designed for, this is the space for it. Schedule you call today here.   Find Jenna on Instagram:  https://www.instagram.com/theuncommonway/  The Uncommon Way is a leadership and business podcast for ambitious women entrepreneurs, founders, and leaders who are scaling companies and expanding their influence. Hosted by business and leadership coach Jenna Harrison, the show explores how power, authority, and leadership capacity shape business growth. Episodes focus on founder leadership evolution, decision-making, team development and stability, and the systemic and strategic shifts that allow companies to scale without overwhelming the person leading them. This podcast is especially relevant for women navigating: • Business growth and scaling challenges • Increasing leadership responsibility • Team expansion and higher-stakes decisions • Founder authority and executive presence • Identity and leadership evolution during scaling The Uncommon Way approaches growth differently. Not through hustle, constant self-optimization, or endless inner work, but by upgrading leadership structures, strengthening decisions, and expanding the capacity required to run the company you're building. Topics include: • Founder leadership capacity expansion • Decision-making at higher levels of responsibility • Authority and power dynamics inside scaling businesses • Structural business leadership • Founder psychology and identity shifts during growth • Sustainable scaling and operational clarity Whether you're an experienced founder, a rising leader, or building something that's starting to matter at a bigger level, this podcast helps you access more power and lead accordingly.  

Today's West Coast Cookbook & Speakeasy Podcast for our especially special Daily Special, Blue Moon Spirits Fridays, is now available on the Spreaker Player!Starting off in the Bistro Cafe, “Pardon Lawyer” Liz Oyer just filed a wrongful discharge suit against the DOJ to get her job back as the chief pardon attorney.Then, on the rest of the menu, the Missouri Supreme Court blocked a Trump-backed US House map and ordered it to be put to a vote; North Carolina mailed its first ballots for the midterm election, as Trump escalates efforts to restrict the practice; and, US diesel prices hit a record high, adding to the political challenges MAGA faces heading into the midterms.After the break, we move to the Chef's Table where the UN watchdog reported Syria was constructing a nuclear reactor in Deir el-Zour under the leadership of ousted former President Assad; and, a Philippine court ordered the arrest of Vice President Sara Duterte over charges that she publicly threatened to have President Ferdinand Marcos Jr and two other people assassinated.All that and more, on West Coast Cookbook & Speakeasy with Chef de Cuisine Justice Putnam.Bon Appétit!The Netroots Radio Live PlayerKeep Your Resistance Radio Beaming 24/7/365!“Structural linguistics is a bitterly divided and unhappy profession, and a large number of its practitioners spend many nights drowning their sorrows in Ouisghian Zodahs.” ― Douglas Adams “The Restaurant at the End of the Universe”Become a supporter of this podcast: https://www.spreaker.com/podcast/west-coast-cookbook-speakeasy--2802999/support.

Credits: 0.75 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  Episode resource links:  Zhou H et al.  Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355.  eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884  Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041   Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257  Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698.  Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930.  Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541.  Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.:  American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022.  Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485.  Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234.  Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455  Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666  Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301.  Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015  Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024  Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0  Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575  Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1  Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Credits: 0.75 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  Episode resource links:  Zhou H et al.  Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355.  eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884  Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041   Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257  Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698.  Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930.  Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541.  Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.:  American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022.  Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485.  Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234.  Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455  Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666  Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301.  Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015  Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024  Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0  Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575  Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1  Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

On this episode, Nathan Silvernail joins the show. He is the co-founder and CEO of Plantd—a company reimagining how structural building materials are manufactured. Before launching Plantd, Nathan spent nearly a decade at SpaceX, where he helped develop advanced manufacturing systems for the Crew Dragon spacecraft. He is now applying that same engineering mindset to […] The post How Former SpaceX Engineers Are Turning Grass into Carbon-Negative Structural Panels first appeared on Composites Weekly.

Do you ever feel lost in the maze of court dates, school meetings, and sleepless nights, forced into a role you never expected? Are you a grandparent who has become the last line of defense for your family, while the system treats your love and sacrifice as just another case number? Maybe you find yourself grieving not just the loss of a peaceful retirement, but the heartbreak of watching your own child struggle, all while building a new life for your grandchildren.I'm Laura, and like you, my life was rewritten the day my grandson was removed from his mother with no warning, a reality no grandparent imagines. Navigating a system that hides its decisions behind a “black box,” my husband and I fought for months to keep our family together, relying on sheer determination and the kindness of a good attorney.Welcome to 'Grandparents Raising Grandchildren.' Here, our focus is on real stories that cut through the silence—stories shaped not only by resilience, but by the cold, hard data that reveals how deeply flawed the system is. You'll hear conversations with experts like this week's episode with Dr. Jill Bryant, a counseling professor and grandmother, who is building the research—and the case—for a future where the well-being of kinship families is not ignored. Complete Dr. Bryant's survey here to help us get the data we need! We'll discuss what it truly means to parent a second time, the grief that goes unspoken, and the shame that lingers in our quiet moments. We'll dig into the nuanced challenges of trauma, the gaps in support, and the power of speaking up—because your experience deserves recognition and your story can drive real change.Join me and a community of 2.7 million strong. Together, we will gather the voices and the data needed to transform the laws and support networks for grandparents raising grandchildren—proving that we are more than a safety net; we are the force for change our families desperately need.Send us Fan MailI want to know how you're doing. Is the podcast giving you what you need? What support are you missing most right now? Send me a Direct Message on Facebook or Instagram or email me directly at laurabrazan@grandparents-raising-grandchildren.org. I read and reply to every message because this community is built on supporting each other! States save billions by leaving children with relatives while giving us zero financial aid, zero legal aid, and zero respite. Leave a comment and let us know your name, state and what support you've been denied? We need to let our lawmakers know what we really need! A listener wrote in after reading this week's newsletter. She commented on how I shared about my husbands grief over the estrangement of his own son. Sign up to receive our weekly newsletters to read the latest stories and share with someone who needs to hear!Thank you for tuning into today's episode. It's been a journey of shared stories, insights, and invaluable advice from the heart of a community that knows the beauty and challenges of raising grandchildren. Your presence and engagement mean the world to us and to grandparents everywhere stepping up in ways they never imagined.Remember, you're not alone on this journey. For more resources, support, and stories, visit our website and follow us on our social media channels. If today's episode moved you, consider sharing it with someone who might find comfort and connection in our shared experiences.We look forward to bringing more stories and expert advice your way next week. Until then, take care of yourselves and each other.Want to be a guest on Grandparents Raising Grandchildren: Nurturing Through Adversity? Send Laura Brazan a message on PodMatch, here: https://www.podmatch.com/hostdetailpreview/grgLiked this episode? Share it and tag us on Facebook @GrandparentsRaisingGrandchilden Love the show? Leave a review and let us know!CONNECT WITH US: Website | Facebook 

What happens when uncertainty hits and a good leader suddenly falls back into old habits? In this episode, I explore why even capable, self-aware leaders can revert to command-and-control when pressure rises and how to recognize when you're leading authentically versus performing the version of leadership you think others expect. You'll learn a simple question to interrupt reactive patterns, identify when you're tempted to take ownership back from your team, and recognize when organizational structures not just personal habits are getting in the way of effective leadership. Top 3 Takeaways: 1. Pressure can trigger old leadership patterns. Even leaders who have done the work can revert to familiar behaviors when uncertainty feels threatening. 2. Authentic leadership requires a moment of choice. Ask yourself: Am I leading from who I actually am, or performing who I think I'm supposed to be? 3. Not every leadership challenge is personal. Structural barriers can limit your team's ownership, so leaders need to distinguish between what they can change themselves and what needs to be addressed within the system. Episode Minutes: Minute 1: The Moment Change Gets Real Minute 3: Authentic Imprint vs Default Performance Minute 6: Give Trust to Get Trust Links + Resources from This Episode: Take the free 3-minute Authentic Imprint™ Assessment Get a copy of Dana's book, The Internal Revolution: Lead Authentically and Build Your Personal Brand from Within Learn more about The Strengths Journal

Meta entered the courtroom facing staggering financial exposure. By the end of Round 1, the plaintiffs had drawn first blood. In this episode of The Valley Current®, host Jack Russo examines how a coalition of state Attorneys General opened its case with hard numbers, damaging internal communications, and a deceptively simple theory: "hook, hold, harvest, hide." Then came whistleblower Arturo Béjar, whose testimony and Meta's own BEEF survey threatened to widen the gap between what the company said publicly and what its internal research revealed about teens' experiences. Meta has serious legal firepower and a credible defense, but this fight is about more than damages. Structural injunctions could reach inside the machinery of its platforms and force changes to the business model itself. Round 1 goes to the plaintiffs. Now Meta has to find a way back into the fight. Jack Russo Managing Partner Jrusso@computerlaw.com www.computerlaw.com https://www.linkedin.com/in/jackrusso "Every Entrepreneur Imagines a Better World"®️  

Credits: 0.75 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  Episode resource links:  Zhou H et al.  Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355.  eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884  Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041   Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257  Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698.  Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930.  Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541.  Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.:  American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022.  Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485.  Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234.  Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455  Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666  Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301.  Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015  Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024  Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0  Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575  Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1  Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Credits: 0.75 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-500 Overview: To celebrate our 500th episode, each member of our team revisits a popular topic from the podcast's earlier installments—GLP-1s, cervical and breast cancer screening, diet and exercise, contraception, hypertension, and lipid management—to trace how the evidence and guidelines have changed since it was first covered. Whether you're catching up or reinforcing what you know, this milestone episode helps you bring the latest evidence into everyday patient care. Guest: Robert Baldor, MD, Alan Ehrlich, MD, Susan Feeney, DNP, FNP-BC; FAANP, Jillian Joseph, PA, Mariyan L. Montaque, DNP, FNP-BC, Jill Terrien PhD, ANP-BC, FAAN   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  Episode resource links:  Zhou H et al.  Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction. Journal of the American Heart Association Volume 14, Number 4 Goff DC et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49–S73. Circulation. 2018 Jul 24;138(4):345-355.  eClinicalMedicine 2025: 103741. Curry, J. (2018). Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA.320(7):674-686. doi:10.1001/jama.2018.10897 https://www.ncbi.nlm.nih.gov/pubmed/30140884  Perkins RB, Wolf AMD, Church TR, et al. Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline. CA Cancer J Clin. 2026;e70041. doi:10.3322/caac.70041   Screening for Cervical Cancer (2026). Obstetrics & Gynecology, 148(1), e63-e67. https://doi.org/10.1097/AOG.0000000000006257  Jad Zeitouni, Nosayaba Osazuwa-Peters, Yusuf Dundar, Gregory Zimet, Mark A. Varvares. (2025). Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity, The Lancet Regional Health - Americas, (51), https://doi.org/10.1016/j.lana.2025.101243 Diabetes, Obesity and Metabolism 28, no. 6 (2026): 5043–5057, https://doi.org/10.1111/dom.70698.  Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis. Am J Med. 2026 Jul;139(7):913-921. doi: 10.1016/j.amjmed.2026.03.010 US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, et al. Screening for breast cancer: US Preventive Services Task Force recommendation statement. JAMA. 2024;331(22):1918–1930.  Trentham-Dietz A, Chapman CH, Jayasekera J, et al. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1931–1946. Giaquinto AN, Sung H, Miller KD, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524–541.  Qaseem A, Harrod CS, Balk EM, et al. Screening for breast cancer in asymptomatic, average-risk adult females: a guidance statement from the American College of Physicians (Version 2). Ann Intern Med. 2026.:  American Cancer Society. Breast Cancer Facts & Figures 2022–2024. Atlanta, GA: American Cancer Society, 2022.  Hu X, Chehal PK, Kaplan C, et al. Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5(8):e2225485.  Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET. Racial differences in breast cancer survival between Black and White women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. 2024;42(35):4225–4234.  Bailey ZD, Krieger N, Agénor M, Graves J, Linos N, Bassett MT. Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017;389(10077):1453–1463. Hypertension. 2026;83:00–00. DOI: 10.1161/HYPERTENSIONAHA.125.25787 Allen RH, Bartz D. Opill: The Over-the-Counter Contraceptive Pill. Obstet Gynecol. 2024;143(2):184-188. doi:10.1097/AOG.0000000000005455  Cahill EP, Kaur S. Advances in contraception research and development. Curr Opin Obstet Gynecol. 2020;32(6):393-398. doi:10.1097/GCO.0000000000000666  Charles DN, Nagarsheth M, Oshman L. Pain Management for IUD Insertion in Primary Care. Am Fam Physician. 2025;111(4):299-301.  Chen, C., Strasser, J., Banawa, R., Luo, Q., Bodas, M., Castruccio-Prince, C., Das, K., & Pittman, P. (2022). Who is providing contraception care in the United States? An observational study of the contraception workforce. American journal of obstetrics and gynecology, 226(2), 232.e1–232.e11. https://doi.org/10.1016/j.ajog.2021.08.015  Diedrich,J., Klein, D. Peipert, J.(2017). Long-acting reversible contraception in adolescents: a systematic review and meta-analysis, Am J Ob Gyn, April 2017. http://dx.doi.org/10.1016/j.ajog.2016.12.024  Li RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, Ho PC, Ng EHY. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023;402(10405):851-858. doi:10.1016/S0140-6736(23)01240-0  Mørch LS, Meaidi A, Corn G, Hargreave M, Wessel Skovlund C. Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems. JAMA. 2024;332(18):1578–1580. doi:10.1001/jama.2024.18575  Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR Recomm Rep. 2024;73(4):1-126. Published 2024 Aug 8. doi:10.15585/mmwr.rr7304a1  Paradise SL, Landis CA, Klein DA. Evidence Based Contraception: Common Questions and Answers. American Family Physician. 2022. https://www.aafp.org/afp/2022/0900/contraception The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Dr. Jenn Simmons and Dr. Bradley Campbell unpack why autoimmune disease is rising, why so many patients are dismissed for years, and why symptom suppression alone often makes things worse. This conversation focuses on root causes, especially gut dysfunction, stress, and immune triggers, and explains why individualized care matters more than one-size-fits-all treatment.Dr. Campbell shares how his work evolved from injury care into complex autoimmune cases, while Dr. Simmons brings the perspective of conventional medicine, cancer care, and the limits of training that does not teach health optimization.Key topicsIn this episode, Dr. Simmons opens with a blunt critique of how poorly autoimmune disease is understood in conventional medicine, especially when labs are “normal” but patients are clearly unwell.Dr. Campbell explains how autoimmune cases found him through patients with chronic, rare, and complex conditions that mainstream care could not resolve.We discuss the gap between medical training and real-world health care, including the difference between knowing how to prescribe and knowing how to create health.Dr. Simmons and Dr. Campbell agree that the system rewards sickness management, not healing, and that insurance incentives often push short visits, prescriptions, and procedures over root-cause work.In this episode: low iron is treated as a major red flag for digestive dysfunction, malabsorption, celiac disease, low enzymes, or bile flow problems, not just a number to supplement away.We discuss why proton pump inhibitors can create long-term digestive problems by reducing stomach acid, impairing digestion, and contributing to dysbiosis and infection risk.Dr. Campbell outlines his autoimmune screening approach, including ANA, ENA panels, thyroid antibodies, hormone testing, food sensitivity workups, and broader root-cause diagnostics.The autoimmune triad comes up in detail: genetics, gut dysfunction, and a trigger such as physical trauma, infection, medication, food reaction, or emotional stress.We discuss parasites as a controversial but real variable in some autoimmune cases, especially in the context of protozoa, gut imbalance, and chronic thyroid issues.Dr. Simmons and Dr. Campbell both push back on rigid diets and medical absolutism, arguing for individualized decisions around grains, dairy, nightshades, and autoimmune protocols.The conversation closes with a strong emphasis on stress, nervous system overload, childhood trauma, and the need for quiet, reflection, and community without constant screen input.Timestamps00:00 - Why autoimmune disease is exploding and often missed for years 03:15 - How Dr. Campbell's path shifted from music and injuries to autoimmune care 06:23 - Why medical training is a foundation, not a complete education in health 08:49 - Doctors as well-intentioned players inside a broken system 11:10 - Why screening versus symptom-based testing must be treated differently 13:20 - Autoimmune disease is highly individualized, even when diagnoses look similar 14:23 - Why celiac disease is often found only after a breast cancer diagnosis 16:36 - Why 30 patients a day leaves no room for root-cause medicine 19:34 - Insurance incentives reward sickness instead of health 23:55 - Years of delayed diagnosis and the cost of being told labs are “normal” 26:52 - Low iron as a clue to digestion, not just iron deficiency 28:19 - Why stomach acid matters for digestion, immune protection, and bile signaling 31:03 - How Heidelberg testing evaluates stomach acidity in real time 33:39 - What Dr. Campbell looks for that many providers miss in autoimmune cases 36:09 - The autoimmune triad: genetics, gut dysfunction, and a trigger 37:34 - Structural, biochemical, and emotional triggers that can set off autoimmunity 40:28 - Parasites, terrain, and why over-treatment is not always the answer 43:44 - Vaccine-era inflammation, informed consent, and autoimmune flare concerns 48:59 - A better model for autoimmune disease: the immune system is trying to do something 51:02 - The autoimmune protocol diet and when a less restrictive approach is better 53:31 - Nightshades, liver function, and why food rules should not be universal 56:13 - Why grains and dairy are not automatically bad for everyone, but can be poor fits in active disease 61:34 - Blood sugar, energy, mood, and why kids often need more real food 63:41 - Why processed protein bars and powders are often worse than whole foods 65:49 - Food transitions at home: why change is hard even when the benefits are obvious 67:46 - Root-cause thinking applies to MS, breast cancer, dementia, osteoporosis, and diabetes 70:03 - Dr. Campbell's membership community, weekly teaching, and lab support 71:30 - GLP-1 drugs: useful tools for some, but not a shortcut for lifestyle change 74:42 - Stress, trauma, quiet time, and why emotional load drives chronic disease 76:55 - Why unresolved trauma and a lack of safety can affect healing for yearsTo talk to a member of Dr. Jenn's team and learn more about working with Dr. Jenn visit: https://calendly.com/stephanie-1031/clarity-callTo get your copy of Dr. Jenn's book, The Smart Woman's Guide to Breast Cancer, visit: https://tinyurl.com/SmartWomansBreastCancerGuideConnect with Dr. Jenn:Website:  https://www.perfeqtionimaging.com/Facebook: https://www.facebook.com/DrJennSimmonsInstagram: https://www.instagram.com/drjennsimmons/YouTube: https://www.youtube.com/@dr.jennsimmons

Today's West Coast Cookbook & Speakeasy Podcast for our especially special Daily Special, Blue Moon Spirits Fridays, is now available on the Spreaker Player!Starting off in the Bistro Cafe, court watchers claim there is a very high probability that Judge Cooper will issue at least a temporary stay against the Board of Trustees of the Kennedy Center to stop the memorial's demolition and renaming.Then, on the rest of the menu, Republican Wyoming Governor Mark Gordon objected to the “very odd behavior” of MAGA election observers who visited a polling station in Cheyenne during last week's primary; a federal judge once again temporarily prohibited the US Postal Service from carrying out a plan to restrict mail-in voting; and, Florida leads the nation in Medicare fraud, so DeSantis laundered over $10 million dollars from a Medicare settlement through his wife's charity to fund his pet political projects.After the break, we move to the Chef's Table where after Trump's most recent embrace of North Korea, the MAGA Pentagon ordered allies on NATO to prove they are stepping up their defense of Europe; and, Nepalese authorities warned all security and rescue personnel to remain on high alert over a newly formed, overflowing lake that could trigger further catastrophic flooding.All that and more, on West Coast Cookbook & Speakeasy with Chef de Cuisine Justice Putnam.Bon Appétit!The Netroots Radio Live PlayerKeep Your Resistance Radio Beaming 24/7/365!“Structural linguistics is a bitterly divided and unhappy profession, and a large number of its practitioners spend many nights drowning their sorrows in Ouisghian Zodahs.” ― Douglas Adams “The Restaurant at the End of the Universe”Become a supporter of this podcast: https://www.spreaker.com/podcast/west-coast-cookbook-speakeasy--2802999/support.

Filipino filmmaker Rafael Manuel discusses his debut feature film “Filipiñana.” Set at an upscale golf country club outside Manila, the film explores inequality, colonialism, structural violence and patriarchy. “Filipiñana” premiered at Sundance where it won the World Cinema Dramatic Special Jury Award for Creative Vision. It opens in New York at Film Forum on Friday.

Filipino filmmaker Rafael Manuel discusses his debut feature film “Filipiñana.” Set at an upscale golf country club outside Manila, the film explores inequality, colonialism, structural violence and patriarchy. “Filipiñana” premiered at Sundance where it won the World Cinema Dramatic Special Jury Award for Creative Vision. It opens in New York at Film Forum on Friday.

In this episode, Thomas K Varghese, Jr, MD, FACS, is joined by Erika Rangel, MD, FACS, from Brigham and Women's Hospital. They discuss Dr Rangel's recent article, “Flexibility Stigma and the Double Bind of Family Formation in Medical and Surgical Residency,” which found that flexibility stigma in residency discourages pregnant and parenting trainees from using needed work-life accommodations, creating harmful double binds between training expectations and personal well-being. Structural and cultural reforms are essential to support equity, retention, and trainee health.   Disclosure Information: All relevant conflicts have been mitigated and Drs Varghese and Rangel, moderators, have no relevant financial conflicts to disclose.   To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. This activity has been designated as Credit to Address Regulatory Mandates in the following categories: Cultural Competency and Behavioral Health. Individuals MUST check with their state or local medical board, hospital, or organization to verify that the content does meet the specific requirements. Listeners can earn CME credit for this podcast for up to 2 years after the original air date.   Rangel EL, Zeineddine J, Lovejoy MC, et al. Flexibility Stigma and the Double Bind of Family Formation in Medical and Surgical Residency Journal of the American College of Surgeons. Published online May 21, 2026. doi:10.1097/XCS.0000000000002046   Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more.   #JACSOperativeWord

Aug. 26, 2026- A new report highlights the abundance of watchdogs for New York's state government, but questions whether they're setup to succeed. We explore these structural challenges with Reinvent Albany Senior Policy Advisor Rachael Fauss.

We hear from Clio Karageorgiou about her work and a recent special issue of Heredity on the same topic - structural variation. Hosted on Acast. See acast.com/privacy for more information.

Listen to Dr. Catherine Bakewell's review of clinical data from a recent label update. Sponsored by Johnson & Johnson Medical Affairs

A review in to the Mount Maunganui landslide concluded no one person was to blame for the tragedy, but a litany of systemic failings led to preventable deaths. The report also made a series of recommendations, including that every natural hazard identified as a risk to life should have a single named person within the council is accountable for its management. Structural and geotechnical engineer Dr Paul Jaquin spoke to Lisa Owen.

You didn't get into animal care work because you wanted an easy career. You got in because you care about animals and the people who love them, well past the point of convenience and ease. In this episode, Emily and Ellen name five patterns we see (and have personally lived) that wear pet professionals down: no client boundaries, no safe space for hard conversations, no clear direction, skipping real self-care, and not believing in yourself.We're talking about what's actually happening to good, committed people in a field with no real standards, no shared training path, and very little permission to talk about the hard things. This isn't an easy episode, but addressing these challenges is what's kept Pet Harmony and our mentees in this field for the long haul. TLDL (too long, didn't listen): 3 Key Takeaways 1️⃣ Boundaries can be systems, not willpower – Structural fixes (like an automated scheduler that just doesn't offer the hours you don't want) hold up better than having to say no over and over in the moment. And it still counts.2️⃣ Isolation and shame feed each other in a loop – Guarding yourself out of fear of looking imperfect only deepens the isolation. The way out is finding people you can be honestly not-okay with. 3️⃣ Self-care is about protecting future you – Not spa days. It's completing your stress response cycle so today's choices don't become a debt your future self has to pay. For the full episode show notes, including the resources mentioned in this episode, go here.Amazon Affiliate StorefrontFind products we recommend at the Pet Harmony Amazon Storefront.As an Amazon Associate, Pet Harmony earns from qualifying purchases.More from Pet HarmonyPet Parents: enrichment ideas and practical behavior tips

It can repair tissue. But then what?Most people think a scan tells them how bad their injury is.And if the damage looks serious enough, surgery will fix the problem.But there's an important distinction that often gets missed.Surgery can repair damaged tissue.It can't rebuild your physical capacity.In this episode, I share a conversation with someone working through our free Coaching In Your Inbox series who is preparing for shoulder surgery.He said something that highlighted a belief I think we need to challenge.That rehabilitation works for some people... but not for others.The reality is more complicated.Whether you choose surgery or not, your body still needs to rebuild the qualities required to function at a high level.Strength.Mobility.Structural balance.Stability.Movement quality.And ultimately, the capacity to tolerate the demands of your training, sport and life.In this episode, I explain why getting out of pain isn't the finish line, why rehabilitation matters both before and after surgery, and why I think about the human body like building a Formula One car.Because the goal isn't simply to repair the broken part.It's to build the entire system so it can handle the racetrack again.If you're currently dealing with an injury, considering surgery, or trying to return to the things you love, this is an important conversation.Click play, and I'll explain what I mean.

What if a few tiny changes to the timing and way you eat could help you think more clearly now, and support the brain you want to have decades from now? For high-achieving women, brain health isn't some abstract concern. Your judgment, creativity, memory, and ability to think clearly are part of how you live, lead, and create value. So when surprisingly simple things can make a difference, they're worth knowing about. From this episode, you'll: Know exactly why I'm eating yesterday's pasta, and the surprising thing that happens when you do Discover the 10-minute post-meal habit that comes with almost no downside Learn 5 surprisingly simple things you can do right now in summer for a sharper mind, without cutting carbs or giving up the foods you love Listen now to discover the surprisingly simple changes that can give you a sharper mind without giving up the foods you love, and why a few small shifts may be more powerful than another complicated optimization plan. Work With Jenna: Decisions on Demand — A practical mini-course designed to help you make cleaner, higher-quality choices,  the kind that unlock momentum, authority, and follow-through. The framework mirrors decision-making principles used in high-stakes environments, adapted for real life and business. The Clarity Accelerator Mastermind — If you want to be surrounded by other visionary entrepreneurs while rapidly aligning your business to the conditions and strategies that let you thrive and excel naturally, this intimate mastermind will stretch you into your next level. Schedule your call today here or visit this page to find out more. Private Coaching — If you're craving the highest level of support, strategy, and partnership to create all the freedom, impact, and success you're designed for, this is the space for it. Schedule you call today here.   Find Jenna on Instagram:  https://www.instagram.com/theuncommonway/  The Uncommon Way is a leadership and business podcast for ambitious women entrepreneurs, founders, and leaders who are scaling companies and expanding their influence. Hosted by business and leadership coach Jenna Harrison, the show explores how power, authority, and leadership capacity shape business growth. Episodes focus on founder leadership evolution, decision-making, team development and stability, and the systemic and strategic shifts that allow companies to scale without overwhelming the person leading them. This podcast is especially relevant for women navigating: • Business growth and scaling challenges • Increasing leadership responsibility • Team expansion and higher-stakes decisions • Founder authority and executive presence • Identity and leadership evolution during scaling The Uncommon Way approaches growth differently. Not through hustle, constant self-optimization, or endless inner work, but by upgrading leadership structures, strengthening decisions, and expanding the capacity required to run the company you're building. Topics include: • Founder leadership capacity expansion • Decision-making at higher levels of responsibility • Authority and power dynamics inside scaling businesses • Structural business leadership • Founder psychology and identity shifts during growth • Sustainable scaling and operational clarity Whether you're an experienced founder, a rising leader, or building something that's starting to matter at a bigger level, this podcast helps you access more power and lead accordingly.  

The Belt and Road Initiative has made fruitful achievements since the Chinese president stressed mutually beneficial cooperation in his speech on the initiative at a symposium exactly 10 years ago (01:15). Iran says it has not yet made a decision to extend the peace memorandum of understanding with the United States, which expires on Monday (13:36). Chinese authorities say the country's economy maintained overall stability in the first seven months of the year with a clear trend toward higher-quality and innovation-driven growth (36:58).

If you're planning to take the Civil PE Structural Exam in 2027, then this episode is a must-listen for you to stay on top of all the exam changes you'll be dealing with on exam day.

Dr. Kurt Olding shares with us the latest published recommendations for conservative treatment for spinal stenosis. Dr. Kurt Olding has been in practice for over 40 years, opening Minster Chiropractic Center in 1986 after graduating from National College of Chiropractic in Lombard, IL in 1984. Through the years Dr. Kurt has enjoyed treating all age groups, from infants to athletes and parents to grandparents. He took special interest in sports medicine during his early years in practice, completing 300 hours of continuing education through the Certified Chiropractic Sports Physician program. Dr. Kurt earned Cox® Technic certification in 2009. In 2012 he began co-instructing the technique, and since 2015 has been a full-time instructor alongside Dr. James Cox, Dr. Ralph Kruse, and Dr. George Joachim. Through his work with Cox® Technic, Dr. Kurt has had several exciting opportunities. In March of 2016, he taught Cox® Technic in Bern, Switzerland as part of the Swiss Chiropractic Academy's "technique series" program. Later that month, he presented research on Cox® Technic with his mentor Dr. James Cox at the annual Association of Chiropractic Colleges Research Agenda Conference. Dr. Kurt co-authored a paper published in the June 2016 edition of the Journal of Chiropractic Medicine titled Chiropractic Distraction Spinal Manipulation on Post-surgical Continued Low Back and Radicular Pain patients: A Retrospective Case Series. In 2015, Dr. Kurt became board certified as a Chiropractic Orthopedist, and a Fellow of the Academy of Chiropractic Orthopedists (FACO). He is also a board member of the Academy of Chiropractic Orthopedists, serving since early 2016. Dr. Kurt and his wife Jackie are Minster natives. They have three children: Sunni, Kregg, and Jack. Sunni and her husband Tyler joined the practice in 2014. Resources: Minster Chiropractic Center kurt.olding@gmail.com Find a Back Doctor thebackdoctorspodcast.com The Cox 8 Table by Haven Medical References: Young I, Dunning J, Butts R, Bliton P, Zacharko N, Garcia J, Mourad F, Charlebois C, Gorby P, Fernández-de-Las-Peñas C. Spinal manipulation and electrical dry needling as an adjunct to conventional physical therapy in patients with lumbar spinal stenosis: a multi-center randomized clinical trial. Spine J. 2024 Apr;24(4):590-600. doi: 10.1016/j.spinee.2023.12.002. Epub 2023 Dec 14. PMID: 38103739. Ammendolia C, Hofkirchner C, Plener J, Bussières A, Schneider MJ, Young JJ, Furlan AD, Stuber K, Ahmed A, Cancelliere C, Adeboyejo A, Ornelas J. Non-operative treatment for lumbar spinal stenosis with neurogenic claudication: an updated systematic review. BMJ Open. 2022 Jan 19;12(1):e057724. doi: 10.1136/bmjopen-2021-057724. PMID: 35046008; PMCID: PMC8772406.   Schneider MJ, Ammendolia C, Murphy DR, Glick RM, Hile E, Tudorascu DL, Morton SC, Smith C, Patterson CG, Piva SR. Comparative Clinical Effectiveness of Nonsurgical Treatment Methods in Patients With Lumbar Spinal Stenosis: A Randomized Clinical Trial. JAMA Netw Open. 2019 Jan 4;2(1):e186828. doi: 10.1001/jamanetworkopen.2018.6828. PMID: 30646197; PMCID: PMC6324321.   Bussières A, Cancelliere C, Ammendolia C, Comer CM, Zoubi FA, Châtillon CE, Chernish G, Cox JM, Gliedt JA, Haskett D, Jensen RK, Marchand AA, Tomkins-Lane C, O'Shaughnessy J, Passmore S, Schneider MJ, Shipka P, Stewart G, Stuber K, Yee A, Ornelas J. Non-Surgical Interventions for Lumbar Spinal Stenosis Leading To Neurogenic Claudication: A Clinical Practice Guideline. J Pain. 2021 Sep;22(9):1015-1039. doi: 10.1016/j.jpain.2021.03.147. Epub 2021 Apr 12. PMID: 33857615.   Comer C, Williamson E, McIlroy S, Srikesavan C, Dalton S, Melendez-Torres GJ, Lamb SE. Exercise treatments for lumbar spinal stenosis: A systematic review and intervention component analysis of randomised controlled trials. Clin Rehabil. 2024 Mar;38(3):361-374. doi: 10.1177/02692155231201048. Epub 2023 Sep 16. PMID: 37715644; PMCID: PMC10829420.   Bise CG, Schneider M, Freburger J, Fitzgerald GK, Switzer G, Smyda G, Peele P, Delitto A. First Provider Seen for an Acute Episode of Low Back Pain Influences Subsequent Health Care Utilization. Phys Ther. 2023 Sep 1;103(9):pzad067. doi: 10.1093/ptj/pzad067. PMID: 37379349.   Hernandez-Martínez J, Cid-Calfucura I, Vásquez-Carrasco E, Perez-Carcamo J, Herrera-Valenzuela T, Aravena-Sagardia P, Barramuño-Medina M, Valdés-Badilla P. Timed Up-and-Go as a predictor of fracture risk: a systematic review and meta-analysis in a population of over 1.6 million people. Front Public Health. 2026 May 11;14:1841017. doi: 10.3389/fpubh.2026.1841017. PMID: 42200137; PMCID: PMC13199231.   Henn MC, Rae A, Fecker AL, McIntyre M, Larsen A, Wright J. A Nationwide Survey of the Spine Education of Medical Students. Cureus. 2026 Apr 4;18(4):e106443. doi: 10.7759/cureus.106443. PMID: 42093772; PMCID: PMC13139429.   James G, Ahern B, Goodwin W, Goss B, Hodges P. ISSLS Prize in Basic Science 2025: Structural changes of muscle spindles in the multifidus muscle after intervertebral disk injury are resolved by targeted activation of the muscle. Eur Spine J. 2025 May;34(5):1600-1613. doi: 10.1007/s00586-025-08646-x. Epub 2025 Jan 15. Erratum in: Eur Spine J. 2025 May;34(5):2046. doi: 10.1007/s00586-025-08744-w. PMID: 39810036.   Gong G, Yan Z, Lai Q, You P, Yu P, Li X, Wang Z, Lin S, Dai Y, Jiang H, Liu J. Inflammation preservation strategy: reconciling pain control and disc resorption in lumbar disc herniation. Front Immunol. 2025 Sep 2;16:1653681. doi: 10.3389/fimmu.2025.1653681. PMID: 40963597; PMCID: PMC12436131.

On this episode of The Distribution, Brandon Sedloff and Raphi Schorr explore what makes inefficient markets the last bastion of alpha in private investing. Schorr, Deputy Chief Investment Officer and Partner at HighVista Strategies, explains how his firm deploys $14 billion across overlooked corners of the market, from lower middle market private equity to venture capital, private credit, and public biotech, where large addressable markets, poor information, and limited competition still reward patient capital and deep networks. They discuss: - Why lower middle market private equity operates beneath the radar of most institutional investors - How backing fund one managers in venture capital creates decades of compounding access - Why 50% of the S&P 500 is venture-backed and what that means for where value is created today - The rise of GP-led secondaries in the lower middle market as sponsors seek to hold their crown jewels longer - How pattern recognition built over 20 years helps identify winning managers and companies in fragmented markets This episode offers a clear view into how experienced allocators find alpha in markets most investors never see. Topics: (00:00:00) - Intro (00:01:05) - Meeting Raphi Schorr and HighVista Strategies (00:02:32) - Mathematics and early investing exposure (00:06:40) - From physics to operations research (00:09:27) - Joining HighVista and the shift to private markets (00:12:10) - Building the firm from day one (00:16:28) - What HighVista does today (00:20:18) - Inefficient markets and where alpha lives (00:24:54) - Pattern recognition in lower middle market PE (00:28:00) - Balancing analytics with relationships (00:31:10) - Access and the venture capital power law (00:34:44) - Backing fund one managers (00:42:29) - Creating optionality through early partnerships (00:48:22) - Structural themes for the next 36 months (00:52:41) - What keeps Raphi up at night (00:54:54) - Closing thoughts on talent and opportunity Speaker Profiles:   Brandon Sedloff     LinkedIn — https://www.linkedin.com/in/bsedloff/     Website — https://brandonsedloff.substack.com/   Raphi Schorr     Linkedin - https://www.linkedin.com/in/raphaelschorr/ Companies:   Juniper Square — https://www.junipersquare.com/   HighVista Strategies — https://www.highvistastrategies.com/

Our Strategist Michelle Weaver talks to Michael Zezas and Jessica Alsford, Co-Directors of the Morgan Stanley Institute, about how AI, energy resilience and industrial policy are changing investment decisions.Read more insights from Morgan Stanley.----- Transcript -----Michelle Weaver: Welcome to Thoughts on the Market. I'm Michelle Weaver, Morgan Stanley's U.S. Thematic and Equity Strategist.Michael Zezas: I'm Michael Zezas, co-director of the Morgan Stanley Institute and Deputy Global Head of Morgan Stanley Research.Jessica Alsford: And I'm Jessica Alsford, Morgan Stanley's Chief Sustainability Officer, and also co-director of the Morgan Stanley Institute.Michelle Weaver: Today: how AI, energy, geopolitics, and industrial investment are competing for scarce resources – and what that competition could mean for markets.It's Friday, July 31st at 10am in New York.Jessica Alsford: And 3 pm in London.Michelle Weaver: Mike and Jess, as co-directors, you speak with people across the firm to identify the biggest questions facing companies and investors, especially the important ones that may not have clear answers yet. And to understand how those questions are shaping client conversations. Mike, what's one of the questions that you think investors are wrestling with the most right now?Michael Zezas: So, one of the biggest questions is how several major investment cycles can happen at the same time. AI, energy infrastructure, manufacturing, and defense may all be competing for the same power, the same skilled labor, equipment, and capital. So, investors need to look beyond each theme in isolation and ask where constraints could delay projects, raise costs, or redirect spending, and which companies are best positioned to manage all of that.Michelle Weaver: Since the institute began, you've examined a number of topics, including AI, energy resilience, and geopolitical fragmentation, just to name a few. Jess, which topic has been the most compelling to you?Jessica Alsford: It's difficult to pick one because, to be honest, for me, it's really the way that AI, energy resilience, and geopolitics have all really become one story. If you think about the energy transition, which has been playing out for a number of years. But now we also have the AI build-out, and that depends on reliable and affordable power. And then geopolitical shocks, which are demonstrating the need for countries to have energy security.So, if you put all of this together and you can really see that there is a huge need to scale the global energy system, but using all types of power available to us, including renewables and nuclear.Michelle Weaver: Mike, how is that intersection that Jess spoke about between AI, energy, and geopolitics altering the way that companies are thinking about investing?Michael Zezas: So, geopolitical shocks, they're more norm than exception now. The situations in Iran, Ukraine, Venezuela, they all reflect an evolving international order where the U.S. is less interested than it used to be in preserving global security and trade standards.And that's a particular problem in a world where companies and governments spent much of the last 50 years optimizing to benefit from globalization. So basically, looking for the lowest cost way to produce things, sourcing materials and labor in the most efficient way possible, presuming that the frictions in international goods and services trade would just keep getting lower.That's obviously not the case now, and whether it's a good idea or not, the trend is toward governments leaning into industrial policy to prioritize supply chain security and protect whatever it sees as their national competitive advantages. And really that's correlated with higher trade barriers. So, that means that while companies are still focused on efficiency, they have to build resilience through more regional supply chains, greater redundancy, and investment in strategically important capacity. So, the practical message from our teams is to map critical dependencies, diversify where possible, and be realistic about the extra cost of resilience rather than assuming the old globalization model will simply return.Michelle Weaver:  One of the clearest constraints on the AI build-out is energy. Our thematic research team is estimating a nearly 40-gigawatt shortfall in power needed for data centers. For context, this is multiple New Yorks worth of power. Jess, how significant of a limiting factor is power becoming?Jessica Alsford: Power is definitely becoming a strategic constraint. If you think about grid connections, these can take years to set up. And so, access to power really is going to determine where facilities are built and how quickly they're able to come online. And it looks like there won't be one universal solution.You've got natural gas, nuclear, renewables, storage, microgrids. They're all going to need to play a role. And for companies, that means that they really are going to have to be planning power alongside the site and financing. For investors, it means focusing on reliability, affordability, and permitting, not just headline demand.Michelle Weaver: So, AI, energy, and geopolitics can no longer be considered in isolation. As countries and companies rethink where they source, build, and invest, where do you see the biggest opportunities emerging?Jessica Alsford: The opportunity is likely to be broader than any single sector, to be honest. and the institute has shown that capital really needs to be flowing towards more resilient supply chains as well as new productive capacity and also the infrastructure that supports both of these. And this covers power, grids, automation, logistics, as well as data. I'd also say that location matters, too. And companies need to be able to weigh political stability as well as skilled labor, reliable energy, and policy support. And investors should be looking for markets and businesses that can turn those advantages into durable returns.Michelle Weaver: The institute has also looked at founders as a source of economic information. Jess, what can their decisions reveal before those changes appear in traditional economic data?Jessica Alsford: So, founders are often making decisions at the leading edge of growth and capital formation, and so their behavior can provide an early read on both at-risk appetite and also financing conditions. If we take the current macro environment as an example of this, the institute has shown that many founders are adapting rather than simply waiting, and this means extending fundraising timelines, spawning investor conversations, and considering private credit, structured equity or tender offers. For companies, the takeaway really is to preserve financing flexibility. And for investors, it's to watch how those choices can reshape private market liquidity.Michelle Weaver: Mike, to bring this back to where we started, if power, labor, and capital are all becoming more constrained, what should investors be watching most closely?Michael Zezas: Yeah. I'd watch whether capital spending plans are being delayed or resized or redirected in some way, and I think importantly, what the reasons would be for any of those things happening.Is there a constraint around power or labor or equipment permitting or financing? Those details help distinguish whether you'd be looking at temporary setbacks or a structural shift. So, something that would signal that we've built too much capacity in AI or manufacturing relative to demand. And that's the type of thing that would be a real headwind to the economic outlook and potentially create problems in the credit markets.But to be clear, we don't see demand flagging anytime soon. And so, for investors, it's less about whether to be bullish or bearish on the outlook for the markets and the economy, and it's more about looking for companies that are durable beneficiaries of these trends. So those are ones with secure inputs, flexible balance sheets, and realistic return thresholds.Michelle Weaver:  Absolutely. As Mike said, we don't see demand slowing, and we're seeing a lot of encouraging data points around AI adoption. One analysis we did recently shows that around 25 percent of S&P companies are now quantifying the benefits they're seeing from AI adoption. And this diffusion story is only going to continue to grow.Mike, Jess, thanks for joining me.Michael Zezas: Thanks Michelle.Jessica Alsford: It's great speaking with you both.Michelle Weaver: And to our listeners, thanks for tuning in. If this is all piquing your interest, you can find the institute's articles, roundtables, and future work on Morgan Stanley's website. And as always, if you enjoy Thoughts on the Market, please leave us a review and share the podcast with a friend or colleague.

High Timeline Living Website:https://www.hightimelineliving.com/Readings with Kristin Lawhead:https://kristiraeastrology.wixsite.com/blogKristin's Pinterest Page:https://www.pinterest.com/kristirae01/?invite_code=abac4e48864546c5be3de92dd3aeea4d&sender=236439186595387133Readings with Alisa Dixon: https://www.astrologywithalisa.com/Fun Astrology YouTube Channel:https://www.youtube.com/@funastrologypodcastBuy Thomas a Coffee!https://www.buymeacoffee.com/funastrologyThank you!Join the Fun Astrology Lucky Stars Club Here!Old Soul / New Soul Podcast - Back Episodes:https://www.buzzsprout.com/2190199https://www.youtube.com/@OldSoulNewSoulAstrologyPodcastDisclaimer: The material in this episode is intended as informational and educational purposes only from an astrological perspective and reflects only the opinions of the presenter. In no way is this podcast considered professional psychological or medical counseling or advice. If you are experiencing a personal crisis, please contact 988 for immediate professional, licensed assistance.